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INTRODUCTION 
 
Siddha system of medicine is most ancient spiritually enriched one. Traditionally it 
is taught that the siddhars laid the foundation for this siddha system of medicine. 
Siddhar,had a wide knowledge about all fields of medicine and excelled in surgical practice. 
Stone inscription in various parts of south India shows the evidence of surgical treatments 
used in olden days. In the ancient literature Pathitru Paththuof cheraa king he its 5
th
part 
includes the versus as follows; 
 
The scar on his chest …scars of glory… 
The scar made by long sutures 
Wrought by needle of silver glow 
Dug and drawn like the fish of cool water  
Down and up as it goes…. 
 
These sequence talks about the instruments used, the type of treatment accorded and 
the efficacy of the surgical treatment in olden days.  
 
As per siddha literature disease are classified into 4448 types, According to sage 
Yugi Vaithiya Sinthamani „‟Neer Izhivu Noi‟‟classified into 20 types called Thithippu Neer 
and it may be correlated with diabetes mellitus in modern aspect. Diabetic complications are 
retinopathy, macular edema, cataracts, glaucoma, neuropathy and ulceration of feet. Saint 
Yugimuni has described the complication of Madhumegam as Avathaigal, which are ten in 
numbers. Ulceration of feet may be correlated with Avathaigal number eight. In the text, 
Agathiyar Rana Vaithiyam; Viranam is classified into two types Thutta Viranam, Athutta 
Viranam. Mathumega viranam comes under the classification of Thutta Viranam. 
 
"²É¡É ±ð¼¡Å ¾Åò¨¾ ¾¡§É 
±Ø¸¢Ãó¾¢ À¢Ç¨Å Ôó¾¡ý Á¢¸×ñ¼¡Ìõ." 
- ä¸¢¨Åò¾¢Â º¢ó¾¡Á½¢ 
 
 
In siddha system of medicine, various types of wound management are performed 
since olden days. There are Thylam (Medicated oil), Neer (Medicated aqueous extract), 
Podi (Medicated powders), Pugai (Wound Fumigation), Seelai (Medicated plaster), 
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Attaividal (Leech therapy), kudineer (Medicated decoction), varti (Wound plug), kalkam 
(Medicinal paste),Vennai (Medicated ghee).These forms are utilized in enabling a wound to 
attain healthy and healing stage from infective state. 
 
"¦¿öì¸¢Æ¢ ¨Åì¸ôÀð¼¡÷,¦¿öôÀò¾ø ¸¢¼ò¾ôÀð¼¡÷ 
 ÒìÌÆ¢±·¸õý¿¡Ê þÕõÀ¢É¡ø §À¡ÆôÀð¼¡÷" 
"ÓÐÁÃô¦À¡óÐ §À¡Ä ÓØ¦ÁöÔõ Òñ¸ÙüÈ¡÷ìÌ 
þÐ ÁÕó¦¾ýÉ ¿øÄ¡÷ þØÐ§º÷ ¸ÅÇõ¨ÅòÐ" 
  º¢ó¾¡Á½¢-¸¡ó¾ÕÅ¾ò¨¾ þÄõÀ¸õ – 324 
 
  
Diabetes is one of the most important and common metabolic disorder that impedes 
the normal steps of the wound healing process. It is classified as either neuropathic, 
neuroischemic or ischemic. High blood glucose level for long duration damage blood 
vessels leads to reduce blood flow to the foot. This poor blood circulation contributed to the 
formation of ulcer and impairs wound healing; loss of sensations develops pressure spots 
and accidentally injures the skin, soft tissue, bones and damage the nerve.  Diabetic ulcer 
affects about 12% of diabetes population. Prevalence rate between0.08 to13%.It was 
estimate that in 2012 approximately 37 million people have diabetes and in every 20 sec a 
lower limb lost due to diabetes globally. In India, it is estimated that approximately 40,000 
legs are being amputated every year, of which 75% are neuropathic with secondary 
infection. Certain factors, such as, barefoot walking, illiteracy, low socioeconomic status, 
ignorance about diabetic foot care these are all high prevalence for diabetic ulcer.  
 
This divine system of medicine is a treasure of numerous herbal, mineral, metals 
and herbomineral medicinal preparation such has Chooranam, Parpam, Chendooram etc. 
There are 32 forms of internal and external medicines. Author chosen Gandhi mathirai 
(Internal) and Sagala ranagalukum kalimbu (External) in the treatment of Madhumega 
viranam. 
 
Ingredients of Gandhi mathirai are Gandhagam (sulphur), Kaatupagal 
(Momorandica dioica), Karunei kizhangu (Typhonium trilobatum), Kadukkai (Terminalia 
chebula)and Sagala ranagalukum kalimbu, Lingam (Cinnabar), Mirutharsingi (Leadore), 
Rasakarpooram (Calomel), Vellai kungilium (Vateria indica), Kadukkai (Terminali 
chebula),Masikkai (Quercus infectorius), Thandrikkai (Terminalia bellerica), 
Kaichukkatti (catechu). 
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kalimbu is effective in treating chronic non healing ulcers. The astringent action of 
sagalaranagalukum kalimbu arrest bleeding in deep ulcers and heals the wound. These 
ingredients are having wound healing activity and anti-diabetic activity hence the author 
preferred this medicinal preparation for diabetic ulcer. 
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AIM AND OBJECTIVES 
 
 
AIM: 
 Preclinical and Open Clinical Trial of Gandhi Mathirai (Internal Medicine) and 
Sagala ranangalukum kalimbu (External Medicine) in the treatment of Madhumega 
viranam (Diabetic Ulcer) 
 
PRIMARY OBJECTIVE:   
 To evaluate the therapeutic efficacy of“Gandhi Mathirai”(Internal) and “Sagala 
Ranangalukum Kalimbu”(External) in the treatment of Madhumega 
Viranam(Diabetic  Ulcer). 
 
SECONDARY OBJECTIVES:   
 
 To study the Siddha basic principles such as Envagai thaervu, Neerkkuri, Neikkuri. 
 To evaluate the safety of the trial drugs by performing toxicological studies, acute 
and chronic in animal models. 
 Biochemical analysis of drug. 
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LITERATURE REVIEW OF MADHUMEGA VIRANAM IN SIDDHA ASPECT 
 
Definition  
An ulcer is a breach of the continuity of the skin, epithelium or mucous membrane 
caused by sloughing out of inflamed necrotic tissue.               
                                                                                                                                                                                                                                    
Aetiology 
 
"§¸¡¨¾Â÷ ¸ÄÅ¢ §À¡¨¾¦¸¡Øò¾Á£ É¢¨Èîº¢ §À¡¨¾ô 
À¡ÐÅ¡ö ¦¿öÔõ À¡Öõ ÀÃ¢×¼ÛñÀ£ Ã¡¸¢ø 
§º¡¾À¡ñ ÎÕÅ Á¢ì¸ Íì¸¢Äõ À¢Ã§Á¸õó¾¡ý 
µÐ¿£ Ã¢Æ¢× §ºÃ ×ñ¦¼É ÅÃ¢óÐ ¦¸¡û§Ç." 
- («¸ò¾¢Â÷-1200) 
 
"þÕÁ¢§ÂÅ¡¾ÓõÀ¢ò¾ãíÜÊø 
ÁÕ×ºÄ §Á¸õ Å¡Õ¾¢ §À¡ÄÌõ 
¯ÕÅõ§Å Ã¡Ìõ ¯ñ¼×¼ø ¸¡ó¾¢Îõ 
¯Õ¸§Å °§É¡Î ¯ È¢ïº¢ þÉ¢ìÌõ 
À¡÷¾¢Îõ ãýÚõ À¾¢óÐ ¦ÁÄ¢óÐ ¿¢ü¸¢ø 
§¾÷ó¾¢Îõ §Á¸õ ¯û§Ç 
§¾¡ýÈ¢Îõ ¦À¡Õó¾¢ ¦ÁöÂ¢ø." 
 
"²É¡É ±ð¼¡Å ¾Åò¨¾ ¾¡§É  
±Ø¸¢Ãó¾¢ À¢Ç¨Å Ôó¾¡ý Á¢¸×ñ¼¡Ìõ." 
- ä¸¢¨Åò¾¢Â º¢ó¾¡Á½¢ 
 
Causes of ulcer in various text, 
 
In the text of Siddhar Aruvai Maruthuvam Viranam, mainly occur due to trauma, 
burns, bite and derangement of humours. 
 
According to the text of Agathiyar Rana Vaithiyam causes of ulcer are, 
 Derrangement of three humours 
 Trauma     
According to the text of T.V. Sambasivam Pillai dictionary, 
 Idiopathic 
 Traumatic 
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Common site of the ulcer 
According to the text of Agathiyar Rana Vaithiyam, 
 Thol (Skin) 
 Iraichi (Muscle) 
 Perunarambu (Arteries and veins) 
 Sirunarambu (Capillaries) 
 Keel (Joints) 
 Elumbu (Bones) 
 Vayiru (Abdomen) 
 Marma nilayangal (Genital organs) 
According to the text of Virana Karappan Sigitchai 
 Thol (Skin) 
 Virai (Blood vessels) 
 Maamisam (Muscle) 
 Thassai naar (Tendon) 
 Sandhigam (Joints) 
 Elumbu (Bone) 
 Kudalgal (GIT) 
 Marma nilayangal(Sirasu-head,irudhayam-heart,siruneerpai-urinary bladder) 
 
Sathiya ranam 
Healthy adults easily recovered from this condition. 
 
Kadina sathiya ranam 
 Thodai (thigh) 
 Yoni (vagina) 
 Aan kuri(Penis) 
 Uthadu (Lips)  
 Muthugu (Trunk) 
 Thadai (Mandible) 
 Kan(Eyes) 
 Pal (Teeth) 
 Naaku (Tongue) 
 Perunarambu (Major arteries and veins) 
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 Sirunarambu (Capillaries) 
 Vayiru (Abdomen) 
 Sevi (Ear)  
 Vila (Rib cage) 
 Akkul (Axilla) 
 Maarbu (Mammillary region) 
 
CLASSIFICATIONOF ULCER 
À¢Èó¾¢Îõ §Ã¡¸ó ¾ýÉ¢ø §À¾§Áô À¢Ã¢òÐô §Àº 
«È¢óÐ §Á¸í¸û ¾ýÛø «ÕÃ½ Á¢ÕÀ¾¡Ìõ 
¦À¡Õó¾¢Â Å¡¾ó ¾ýÛø ¦À¡ÕÃ½ ¦Á¡ýÀ¾¡Ìõ 
ÁÕó¾¢Âø À¢ò¾õ ÀòÐ ÅÇ÷º¢§ÄüÀÉõ Àñ½¢¦Ãñ§¼. 
- «¸ò¾¢Â÷ Ã½áø 
According to the text of Agathiyar Rananool ulcer can be classified into three types there 
are Vatham – 9, Pitham – 10, Kabam - 12 
Major classification of ulcer in the text of Agathiyar Rana Vaithiyam, 
 Vathapithakabam  - Nija Viranam 
 Thondham   - Aaganthu Viranam 
Sutha viaranam 
 
Depending upon the symptoms ulcer is classified into two types there are  
 Thutta viranam- 4 
 Athutta viranam - 45 - Agathiyar Rana Vaithiyam 
 
In the basis of derangement of three biological humors ulcer can be classified into 16 
types, 
 Vali pun 
 Pitha pun 
 Iyya pun 
 Vali pitha pun 
 Vali iyya pun 
 Pitha iyya pun 
 Mukkutra pun 
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 Kuruthi pun 
 Kuruthi thee pun 
 Kuruthi vali pun 
 Kuruthi iyya pun 
 Kuruthi vali pitha pun 
 Kuruthi vali iyya pun 
 Kuruthi pitha iyya pun 
 Kuruthi mukutra pun 
 velutha kuruthi pun 
-Siddhar Aruvai Maruthuvam 
 
Classification of ulcer in the text of T.V.Sambasivam Pillai dictionary, 
 Neruppu pun (Burns) 
 Mega pun (Venereal ulcer) 
 Vellai pun (Gonorrheal ulcer) 
 Aaraa pun (Chronic non healing ulcer) 
 Kiranthi pun (Syphilitic secondary rashes) 
 Ottu pun (Contagious sore) 
 Kuzhi pun (Deep sore or perforating ulcer) 
 Raasa pun (Diabetic carbuncle) 
 Karappan pun (Eczema) 
 Parangi pun (Syphilitic primary sore) 
 Vettu pun (Incised wound) 
 Kaaya pun (Traumatic ulcer) 
 Azhi pun (Sloughing sore) 
 Korukku pun (Chancre) 
 Veditha pun (Fissure ulcer) 
 Azhar pun (Inflammed ulcer) 
 Rasavekkadu pun (Ulcer caused by mercurial poisoning) 
 Putru pun (Fungus ulcer) 
 Vayitru pun (Gastric ulcer) 
 Thulai pun, Purai pun (sinus) 
 Ari pun (Rodent ulcer eating away the tissues) 
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In the text of siddha system of diseases ulcer classified into, 
 Saruma pun (dermatitis) 
 Adhirvu pun (dermatitis traumatica) 
 Thee pun (dermatis calorica) 
 Kulirchi pun (chill blains or frost bite) 
 Azhu pun (dermatitis gangrenosa) 
 Nanju pun (dermatitis medicamentosa) 
 Veppu noi pun (pruritis and urticaria) 
 Kiranthi (venereal ulcer) 
 Korukku pun (chancroid) 
 
SYMPTOMS OF ULCER: 
According to the text of Siddhar Aruvai Maruthuvam, classification of ulcer based on 
the derangement of three biological humors, 
S. 
NO 
TYPE COLOUR 
PAIN/ BURNING 
SENSATION 
DISCHARGE / 
SMELL 
ONSET 
1. 
 
Vali pun black, red or 
white in color 
pricking pain purulent discharge - 
      
2. Azhal pun yellow, red, 
dark red or 
pale red in 
color 
pain and burning 
Sensation and redness 
present in ulcer 
Clear discharge Acute 
3. Iyya pun Pale in colour Itching and pricking 
pain 
Sticky discharge Gradual 
4. Vali pitham Redness Pricking pain Clear and scanty 
discharge,foul smell. 
- 
5. Vali iyyam Pale in colour Pricking pain and 
itching present 
Sticky discharge - 
6. Pitha iyyam Pale in colour Burning sensation and 
pain present,mild heat 
present around the 
ulceration 
Sticky discharge  
 
- 
7.  
Mukkutram 
 
Which present in the mixture of vaatham,pitham,kabam 
8. Kuruthi pun Red or coral 
in  colour 
Very Painful Bloody discharge and 
symptoms are similar to 
dhutta viranam 
- 
9. Kuruthi vali 
pun 
Red in colour Rough,severe pain is 
found 
Bloody stained 
discharge 
- 
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10. Kuruthi 
pitha pun 
Red and 
yellow in 
colour 
Mild pain present Clear discharge and 
bloody stained 
- 
11. Kuruthi 
iyya pun 
Red in colour Swelling and itching 
present 
Bloody discharge - 
12. Kuruthi vali 
pitha pun Mixture of features of both  kuruthi vali pun and kuruthi pitha pun 
13. Kuruthi vali 
iyya pun Mixture of features of both  kuruthi vali kuruthi iyya pun 
14. Kuruthi 
pitha iyya 
pun 
Mixture of features of both kuruthi pitha and kuruthi iyya pun 
15. Kuruthi 
Mukkutra 
pun 
Mixture of the features of kuruthi vali,pitham,iyyam 
16. Velutha 
kuruthi pun 
Ulcer is pale red in colour, centrally elevated,and shiny without any 
discharge. 
 
According to Agathiyar Rana Vaidhyam, 
Dhutta viranam  :  4 
Athutta viranam :   15 
Dhutta viranam    Chronic non healing ulcer 
Athutta viranam : Healing ulcer purulent discharge present in the  
ulceration. 
Sutha ratha viranam :   Papular lesion present around the ulceration with  
raised floor. 
Dhutta viranam sub types: 
 
1. Dhutta vaatha viranam – ulcer black and white in colour.it may be deep seated and 
sometimes penetrating the bone, pricking pain with purulent discharge present 
around the ulceration. 
 
2. Dhutta pitha viranam – ulcer is reddish white or yellow in colour, sudden 
onset,clear discharge present in ulceration,burning sensation and pain preset around 
the ulcer. 
 
3. Dhutta silaethuma viranam – raised edge, itching and pain present in the 
ulceration discharge sticky in nature. 
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4. Rathavaatha dhutta viranam – bright red in colour or coral like colour,blood 
stained discharge present in ulceration. 
 
According to Anubava Vaithya Deva Ragasiyam, 
Sathiyo viranam 
 Krishta viranam   -  It is a chronic non–healing ulcer occurs due to 
     accidentally injure with thorn and horn. 
 Avakartha viranam  -  It is perforated with deep seated ulcer 
 Vichinna viranm  -  cut wound 
 Piravilambi viranam  -  Ulceration is cut wound and it may deep seated 
     with penetrating to the wound. 
 Nibaathika viranam  - Compared with gangrene stage, in this type  
     ulceration involve with bone and it can be  
     surrounded by necrotizing tissue. 
 Vitha viranam   -  Traumatic ulcer 
 Pinna viranam   -  Mainly due to injure with sword, sharpie  
     instruments. 
 Vithalitha viranam  -  Bleeding ulcer, it may lead to arthralgia and  
     spreading nature. 
 
According to Viranakarappan Roga Sigitchai: 
Nija viranam 
 Simple ulcer, it‟s occurring due to derangement of three humours. 
 
Aaganthu viranam 
This type occurs mainly due to trauma. 
 
Dhutta viranam: 
 Margin of the ulcer it may be closed or open; it may be extensively soft or hard in 
nature. 
 Base of the ulcer is raised or deep seated 
 Surrounding area may be inflamed or not 
 Color of the ulcer is red, white, and black.  
 Purulent discharge 
 Ulcer is very painful, itching, swelling present around the ulcer. 
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Sutha viranam: 
 Ulcer may be pale in color, surrounding area hyper pigmented with purulent 
discharge and inflamed. 
 
Curable and incurable conditions of ulcer: 
 
ÒñÏõ¦ÅÙòÐ ¿£÷Á¢ÌóÐ §À¡¾ìÌòÐÅÄ¢ Á¢Ìó¾¡ø 
¯ñ¨ÁôÀ¼§Åý ¦ºí¸Äí¸ø ¦¸¡ûÇ¡¾¢Õì¸¢æý ¦ºöÔõ 
¾¢ñ¨ÁôÀ¼§Å ¦ºí¸Äí¸ø Â¢Ãò¾Á¡¸¢ü ¾£Ã¡Ð 
¿ýÉ¢ì¸¢Æ¡öî º£úÅ¢ØóÐ À¢ý¨É¿¨ÉìÌï ¦ºõÒñ§½ 
      -  Å¢Ã½¸ÃôÀ¡ý º¢¸¢î¨º 
According to the Viranakarappan Sigitchai, 
Curable  
 Healthy adults 
 If the shape of the ulcer is oval or circular are easily curable 
 Maintain proper hygienic improves the wound healing process. 
 If the ulcer develops in male genitalia, lips, oral cavity it can be easily treatable. 
 
Incurable 
 Ulceration with extensive destruction or tissue necrosis or surgical removal of blood 
vessels may interrupt the healing process. 
 Ulceration involves in tendon, muscle, bone delays wound healing process. 
 Improper medication and dressing 
 Toxic bite induced ulcer 
 Alcohol 
 
Siddhar Aruvai Maruthuvam 
Curable 
 Age of affected person 
 If the shape of the ulcer is oval, triangle, rectangles are easily curable 
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Incurable 
 Improper medication may delay the wound healing process. 
 Chronic ulcer with secondary infections such as TB, leprosy which may delays the 
wound healing process. 
 If ulceration develops in eyes, nostrils, abdomen, chest and joints may interrupts the 
wound healing process. 
 Ulcer with increased purulent discharge, raised floor, extensive and localized 
gangrene, osteomyelitis, deep ulceration with bone and tendon, joints  this condition 
are difficult to treat.  
 If the ulcer occur in vertex, fingertip, vital points, deep seated wound which 
penetrate the bone and bone marrow are difficult to treat. 
 
WOUND CARE IN SIDDHA ASPECT: 
According to text of Viranakarappan Roga Sigitchai- Banthanam (Bandaging); 
There are 15 types of bandaging methods are described 
Kosabandhanam 
Svasthiga banthanam 
Muthhtoli banthananam 
Seena banthanam 
Thaama banthanam 
Anuvellitha banthanam 
Katvaa banthanam 
Vibantha banthanam 
Sthagitha banthanam 
Vithaana banthanam 
Uthsanga banthanam 
Koobana banthanam 
Yamaga banthanam 
Mandala banthanam 
Panchanga banthanam 
Indication 
 Traumatic ulcer 
 Cuts 
 Ulcer with purulent discharge conditions 
 Bleeding ulcer 
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Contra -Indications: 
 Hansen‟s ulcer 
 Burns 
 Diabetic ulcer 
 Herpes zoster 
 
KATTU-(COMPRESS OR BANDAGE) 
kattu is an application of covering of a specially prepared topical medicine made up 
of crude plants, birds, fermented water or inorganic substance on the affected area is known 
as kattu.  This procedure is usually done for three times, at an interval of 3-7 days. 
 
Indication 
 Abscess 
 Carbuncles 
 Supperative and Non supperative ulcer 
 
Contraindication 
 Deep ulcers with foreign bodies 
 Cellulitis 
 
PATRU-(SEMISOLID POULTICE) 
The raw materials are either ground or juices of leaf, bark, root are heated or not 
heated and applied or paste on the affected area. It is a soft moist, usually made up of 
herbals which is applied in the skin diseases, abscess as emollient, anti-microbial and anti-
allergic. This method is commonly used to treat wound and abscess where the built up pus 
needs to draw out.  
Indication 
 Abscess 
 Carbuncle 
 Initial stage of ulcer  
Contraindication 
 Deep ulcers 
 Gas gangrene 
 Cellulitis 
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POOCHU-(LIQUID POULTICE) 
 
This is the external application of leaf juice in affected area, normally the medicine 
in the liquid form either in oil base or water base is spread evenly on affected area. Its 
develops a thin layer spread on the affected areas due to its liquid nature.it is also called as 
ellai poochu ,kashaya poochu, ennai poochu etc. This procedure involves the purification, 
lubrication, moisturization, local healing, and analgesic.   
 
Indication 
 Wounds  
 Sinus ulcers 
 Fissure foot 
 Ulcer with hyperpigmentation 
 
Contraindication 
 Cellulitis 
 Traumatic ulcer 
 
KALIMBU-(OINTMENT APPLICATION) 
This is a form of medicine used externally in the form of ointment. In this certain 
mineral compounds astringent material like Terminalia chebula are powdered and grounded 
with butter and applied over wounds and ulcer. 
 
Indication 
 Chronic skin ulcers 
 Fissure 
 Abscess 
 
Contraindication 
 Direct contact with eyes 
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SEELAI-(PLASTER APPLICATION) 
 
This type of external medicine is in the form of medicated plasters. Plasters are 
prepared by grinding herbal or mineral material in water or herbal juices. A piece of cloth is 
soaked in this and externally applied over wounds. Medicated gauze is used for the 
application of a wound in order to promote healing and prevents further harm. This method 
is absorbed the exudates and debris from a wound and promotes the healing by fastening the 
epithelial formation. 
 
Indication 
 Chronic non healing ulcers 
 Fissures 
 Abscess 
 Fistula 
 
Contraindication  
 Malignant growth using caustic plasters 
 
NEER-(MEDICATED LIQUIDS) 
Neer is defined as the method of soaking the drugs into the water or making a 
decoction or dissolving the dry powder into the water and the filtered solution is applied 
over the affected area to treat or wash.  
E.g. Padigara neer, Veera neer, are used in washing wounds. 
 
Indication 
 Acute and chronic ulcers 
 Apthous ulcer 
 Eczema 
 Fissure  
 Fistula 
Contraindication 
 Perforated ulcers 
 Necrosis 
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VARTHI- (MEDICATED WICK) 
 
This type of external medicine is in the form of medicated wicks. Caustic substances 
are ground well with herbal juices or decoctions; a piece of cloth soaked in this and a wick 
is prepared. These wicks are applied or inserted into granulomatous tracks in fistula, sinus, 
and non-healing ulcers. 
 
Indication 
 Abscess 
 Carbuncle 
 Chronic and perforated ulcer 
 Fistula 
 Sinus 
 Infected ulcer with tissue growth 
 
Contraindication 
 Septicemia 
 
PASAI-(EMBROCATION APPLICATION) 
 
Pasai is defined as the mixture of medicated powders with specific oil melted honey 
bee wax.its otherwise called as lepam or mezhugu.These are semi-solid lipid or resin or gum 
based application. Usually fats are used as bases of vegetable oiland bee wax. They protect 
and stay in the skin as emollient for a long time. 
 
Indication 
 Abscess 
 Ulcer  
 
Contraindication 
 Direct eye contact 
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PODI-(MEDICATED DUST OR POWDER APPLICATION) 
 
Podi is defined as the finely powdered raw drugs used to sprinkle affected areas.it is 
dusted over the chronic weeping or purulent wound.it has two types one is dry powder for 
sprinkling,dry powder mixed with oil or liquids. 
 
Indication 
 Wound  
 Non healing ulcer 
 Eczema 
 
Contraindication 
 
 Eyes and nasal application 
 Nasal inhalation 
 
SUTTIGAI-(CAUTERIZATION) 
 
This is destruction of tissues with a cautery. They are traditionally used to stop 
heavy bleeding; this would cause tissues and blood to heat rapidly to extreme temperature 
causing coagulation of the blood this control bleeding. According to the physical nature and 
administration, it is classified into five types, Mann suttigai(application of mud or 
stone),Mara suttigai(application of hot plantparts),kaal suttigal(application of hot 
air),kaanthi suttigai(application of sun rays), Uloga suttigai(application of hot metals). 
 
Indication 
 Wounds especially bleeding ulcers 
 Non healing ulcer 
 Infected ulcer with tissue growth 
 Carbuncle 
 Deep ulcers 
 Fistula 
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Contraindication 
 Burn shock 
 Dehydration 
 Keloid  
 Sun stroke 
 
PUGAI-(FUMIGATION) 
 
Fumigation is method of applications in which the medicated fume is generated by 
burning the drugs directly or putting the drugs into the fire. It commonly expose on the site 
or exposing fume on septic wound by burning a medicated wick. 
 
Indication 
 Chronic non healing ulcer 
 Fistula 
 
Contraindication 
 Status asthmaticus 
 Suffocation 
 Immediately after eye operation 
 
URINJAL–(PIPE ASPIRATION) 
 
Urinjal is a suction process using a special probe or aspiration process using a needle 
to exudates the waste fluid or unwanted fluids from the body parts.it plays an important role 
during surgical process to aspirate and drain the accumulate fluids such as pus, blood. 
 
Indication 
 Abscess 
 Carbuncle 
 To remove unwanted material from deep-seated ulcer 
 
Contraindication 
 Blood coagulation 
 Coronary artery disease 
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KURUTHI VANGAL–(INSTRUMENTAL BLOOD LETTING) 
 
Kuruthi vangal is an external method of application of sharp instruments to leak or 
remove the blood from the abscess, cyst, keloid or the area where the accumulated blood are 
seen. In this type of treatment a minor incision is made on the blood vessel and the excess 
of blood is let out. Types are one is incision to let normal blood in bloodletting therapy and 
another one is incision to let purulent or impure blood from the affected area. 
 
Indication  
 Transudate and exudate 
 Abscess 
 Cyst 
 
Contraindication 
 Convulsion 
 Pregnancy 
 Tuberculosis 
 
KEERAL - (INCISION AND DRAINAGE) 
 
Keeral is an incision to remove blood or pus or mucus from the abscess, cyst.Keeral 
or incision helps to remove the accumulated pus,blood by using the sharp probe. The sharp 
probe used for this called kombi, it‟s about 25 cm length, and in brow shape.  
 
Indication 
 Abscess 
 Carbuncle 
 Sebaceous cyst 
 
Contraindication 
 Blood coagulation disorder 
 Tumor 
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KARAM-(CHEMICAL CAUTERIZATION) 
 
Karam is application of caustic chemicals on the affected area to excise or remove 
the unwanted tissue or slough and debris. This procedure used to remove the slough, debris 
and unwanted growth and improves the healing process of the non-healing ulcer. It is the 
method of the application of medicated caustic drugs over the area of the chronic ulcers. 
 
Indication 
 Abscess 
 Chronic non healing ulcer 
 Cancerous foul smell growth 
 Fistula 
 
Contraindication 
 Pain shock 
 Localized gangrene 
 Deep seated ulcer 
 
ATTAI VIDAL-(LEECH THERAPY) 
 
Attai vidal is an external method of application of medicinal leech to remove impure 
blood from the affected site. According to Therayar tharu, leech therapy is classified into 4 
types. In wound management leech therapy can be used to treat chronic venous ulcer, non-
healing ulcers. No of leech is depends upon the e site and nature of diseases. Leech saliva 
contains the presence of a variety of bioactive peptides,proteins involving anti-thrombin and 
anti-platelet, factor Xa inhibitors and others, these active molecules used to treat many 
chronic illness.  
 
Indication 
 Varicose ulcer 
 Varicose eczema 
 Keloid 
 
Contraindication 
 Blood coagulation disorder 
 Coronary heart disease 
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SIDDHA PATHOLOGY 
According to the siddha aspect, a disease occurs mainly due to the derangement of 
three biological humours namely Vatham, Pitham, Kabam. In diabetes, ulceration mainly 
occurs due deranged kabam and physical constituents of the body.  
 
PINIYARI MURAIMAI (DIAGNOSTIC METHODS):  
 
Piniyarimuraimai is the method of diagnosing disease. It is based on the following 
principles:  
Poriyal aridhal  
Pulanal aridhal  
Vinaathal  
 
Poriyal aridhal and Pulanal aridhal means examining the patients „Pori‟ and „Pulan‟ with 
that of  physicians, ori‟ and „Pulan‟.  
 
Imporigal  
 
 Mei (Skin)  
 Vai (Tonge)  
 Kan (Eyes)  
 Mooku (Nose)  
 Sevi (Ear)  
 
Impulan:  
 Osai (Sound)  
 Ooru (Sensation)  
 Oli (Vision)  
 Suvai (Taste)  
 Naatram (Smell)  
 
Vinathal:  
“Vinaathal‟ is a method of enquiring about the details of the patient‟s problem from 
his own words or from his parents or attenders who are taking care of the patient, when the 
patient is not able to speak (or) if the patient is a child. 
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Envagai thervugal (Eight tools of examination) 
 
¾Ã½¢Â¢ÖûÇ Å¢Â¡¾¢¾ý¨É Âð¼¡í ¸ò¾¡ø 
¾¡ÉÈ¢Â §ÅñÎÅÐ §Â§¾¡ ¦ÅýÉ¢ø 
¾¢Ã½¢Â§¾¡÷ ¿¡Ê¸ñ¸û ºò¾ò §¾¡Î 
§¾¸ò¾¢ÉÐ ÀÃ¢ºõ ÅÕ½õ ¿¡ìÌ 
þÃ½ÁÄ ãò¾¢ÃÁ¡ Á¢¨Å¸ ¦ÇðÎõ 
þ¾õÀ¼§Å ¾¡ýÀ¡÷òÐì ÌÈ¢ôÒí ¸ñÎ 
ÀÃ½ÕÇ¡ø ¦ÀÃ¢§Â¡÷¸û À¡¾õ §À¡üÈ¢ô 
ÀñÒ ¾ÅÈ¡Áø ÀñÊ¾ï ¦ºöÅ£§Ã - Ì½Å¡¸¼¿¡Ê 
 
Sparism -  To examine the sensation, temperature and nature of the skin  
Naa   -  To examine the Colour of saliva, sputum and nature of speech. 
Niram  -  To examine the Variation in pigmentation of skin. 
 
Mozhi 
- Vaatham (Normal pitch)  
- Pitham (High pitch)  
- Kabam (Low pitched)  
- Thontham (Mixed all the above)  
 
Vizhi    
- Vaatham (Black in colour, increased lacrimation))  
- Pitham (Yellow or red in colour)  
- Kabam (White in colour)  
 
Malam 
- Vaatham (Stools are black in colour and constipated)  
- Pitham (Yellowish white in colour)  
- Kabam (White in colour)  
- Thontham (Mixed colour)  
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Moothiram  
Collection of urine for the determination of Neerkkuri and Neikkuri, is an important 
diagnostic method 
 
NAADI NADAI 
In viranam,  
 
Å¡¾¸À ¿¡Ê 
''þÕìÌÁó¾ Å¡¾ò¾¢ø º£¾ï §º÷ó¾¡ø 
þ¨ÇôÀ¢ÕÁø Å¢¼ºó¿¢ §¾¡¼õ Å£îÍ 
ÁÕì¸¢ýÈ ÌÇ¢÷¸¡öîºø Å¢Ã½ §¾¡¼õ 
Å¡ó¾¢ ±Îò¾¢ÎÓ¨Ç× ÁÂì¸ï §º¡÷× 
´Õì¸¢ýÈ ÁÄÀó¾õ ¦À¡ÕÁø Å£ì¸õ 
¯ûÅ£îÍ Ý¨Ä§Â¡Î À¡ñÎ §Ã¡¸õ 
¾Õì¸¢ýÈ ¾Û÷Å¡¾õ Àì¸Å¡¾õ 
º¡÷óÐ¦ÅÌ À¢½¢ÀÄ×ó ¾¨ÆìÌõ À¡§Ã.'' - º¾¸ ¿¡Ê 
¸À¿¡Ê 
''¾¡ÉÓûÇ §ºòÐÁó¾¡ É¢Ç¸¢ø ¦ÅôÒ  
ºÂÁ¢ÕÁø ®¨ÇÁó ¾¡Ã ¸¡ºõ 
®ÉÓÕï ºó¿¢Å¢¼ §¾¡¼õ Å¢ì¸ø 
þÕòÐ§Ã¡¸í ¸ÃôÀ¡ý Å¢Ã½ §¾¡¼õ  
Á¡É¨ÉÂ£÷ Ý¨Ä¾¢Ãû Å¢Â¡¾¢ Å£ì¸õ 
ÅÕïºì¾¢ ÍÅ¡ºõ¦¿ï º¨¼ôÒ,Ðì¸õ 
²ÉÓÚí ¸¡Á¡¨Ä À¡ñÎ §º¡¨À 
²ØÍÃí¸û ÀÄÐì¸õ Å¢¼Óñ¼¡§Á''  - º¾¸ ¿¡Ê 
Vaathakabam, Kabam Naadi could be felt in ulceration condition. 
 
NEERKURI 
''Åó¾ ¿£Ã¢ì¸Ã¢ ±¨¼ Á½õ Ñ¨Ã ±ïº¦Äý 
¨Èó¾¢ÂÖÇ¨Å Â¨ÈÌÐ Ó¨È§Â.'' - §¾Ã÷¿£÷ÌÈ¢ ¦¿öÌÈ¢ áø 
25 
 
Before the day of urine examination instruct to the take balanced diet and good 
sleep. After waking up in early morning, the first urine should be collected in a clear wide 
mouthed glass container and is subjected to analysis of Neerkuri within 1
1/2 
hours 
 
NEIKURI 
 
The collected specimen should be kept in open container or glass bowl.it is to be 
examined under direct sun light, without shaking of vessel. Then add one drop of gingili oil 
without disturbing the urinary specimen. The Neikuri was noted in direct sunlight and 
conclude the diagnosis. 
 
''Òñ½¢÷ §Á¸ôÒñ¸ñ Á¡ôÀ¢½¢ 
¿ñ½¢ø ¿¢ò¾¢Â ¿¡¾¢Âõ ¬¦ÁÛõ.'' - ¿¢ò¾¢Â ¿¡¾¢Âõ 
In diabetic ulcer, the collected urine sample appears in red color. 
 
LINE OF TREATMENT: 
 Neekam (Treatment) 
 Niraivu (Rejuvenation) 
 Kaapu (Prevention) 
 
NEEKAM (TREATMENT) 
 Viresanam 
 Internal medicine 
 External medicine 
 
Viresanam 
Viresina sigichai mainly used to equalize derangement of three biological humours 
and also restoring the physiological constituents of Thathu.  
 
'Ð¸¢ýÈ ÁÄì¸ø¨¼ ¦Â¡Æ¢Â ¨Åò¾¡ø 
¯¼Ä¢ÖûÇ Å¡¨¾¦ÂÄ¡ ¦Á¡Îí¸¢ô §À¡Ìõ' 
According to the text of siddha vaithiya thirattu, 
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þÎ¸ñ½¢ü ¸Î¸¢ü À¡¾¢ 
Å£íÌ¸ü È¡Æï §º¡Ú 
ÅÊ¾Â¢÷ ºó¾Éí¸û 
¨ÅòÐ¿£ ¸ð¼ Á¡Úõ 
ÀÎÀÕõ À¢Ç¨Å Å¡¨Æ 
À¸¨Ã Â¡ôÒô Òñ¸û  
¯¼ÖÚ º¢Äó¾¢ ¦¸¡øÄ¡ 
ÓÁ¢ú ¿£Ã¢ü âº ¿ý§È  - º¢ò¾ ¨Åò¾¢Â ¾¢ÃðÎ 
 
In viranam, Agasthiyar kulambu can be applied externally and internally it can be 
given with Sangankuppi Charu. 
 
Anubanam: 
«ÛÀ¡Éò¾¡§Ä ÂÅ¢ú¾õ ÀÄ¢ìÌõ 
þÉ¢¾¡É ÍìÌ þïº¢ - À¢É¢ÓÐ¸¡ø 
§¸¡ÁÂõÀ¡ø Ó¨ÄôÀ¡ø §¸¡¦¿ö§¾ý ¦ÅüÈ¢¨Ä¿£÷ 
¬Á¢¨¾Â¡ Ã¡öóÐ ¦ºöÂÄ¡õ - §¾¨ÃÂ÷ ¦ÅñÀ¡ 
 
Pathiyam (Dietary Regimen):  
In siddha aspect treatment can be given based on taste whichneutralize the three 
biological humours and restore the physical constituents of the body. Arusuvai and 
thirithodam are interlinked. Predominance of kaatru, and thee element express the pungent 
taste, man and kaatru element express the thuvarpu taste, both are having the hot potency. 
In suvai basis pungent and astringent taste which cures the ulcer formation, skin disease etc.  
As the hot potency has the action of curing ulcers, pungent and astringent taste with hot 
potency helps in curing ulcers.  
 
Niraivu(Rejuvenation) 
The substance used for neutralising the three biological humours there are; 
´ýÈ¢Â Å¡¾À¢ò¾õ ¸ÀÁ¢¨Å ÔÂÃ¡Åñ½õ 
¿ýÈÐ ¸È¢¸¦ÇøÄ¡õ ¿¡Ù§Á º¨ÁôÀ¡Ã¡öó§¾¡÷ 
¾¢ýÈ¢Î Á¢ÇÌ Áïºû º£Ã¸ÓÂ÷ó¾ ¸¡Âõ 
¦ÅýÈ¢¦¸¡û Íì§¸¡§¼Äõ ¦Åó¾Â ÓûÇ¢ §º÷ó§¾    
       - À¾¡÷ò¾ Ì½º¢ó¾¡Á½¢ 
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Kaapu (Prevention) 
 
Ideal measures mentioned in the siddha classical text Pathartha guna chinthamani 
for for healthy living as below, 
 
¾¢ñ½Á¢ÃñÎû§Ç º¢ì¸ Å¼ì¸¡Áü 
¦Àñ½¢ýÀ¡ ¦Ä¡ý¨Èô ¦ÀÕ¸¡Áø ¯ñÏí¸¡ø  
¿£÷ÍÕì¸¢ §Á¡÷¦ÀÕì¸¢ ¦¿öÔÕì¸¸¢ ÔñÀÅ÷¾õ 
§ÀÕ¨Ãì¸¢ü §À¡§Á À¢½¢.  - À¾¡÷ò¾ Ì½º¢ó¾¡Á½¢ 
 
 
¬Ú¾¢í¸ð ¦¸¡Õ¾¼¨Å ÅÁÉ ÁÕó ¾Â¢ø§Å¡õ 
 «¼÷ ¿¡ýÌ Á¾¢ì¦¸¡Õ¸¡ü §À¾¢Ô¨È Ñ¸÷§Å¡õ 
§¾ÚÁ¾¢ ¦Â¡ýÈì§¸¡÷ ¾Ã¿º¢Âõ ¦ÀÚ§Å¡õ 
 ¾¢í¸Ç¨Ãì ¸¢ÃñÎ¾Ãï ºÅÃÅ¢Õô ÒÚ§Å¡õ 
Å£ÚºÐ÷ ¿¡ð¦¸¡Õ¸¡ø ¦¿öÓØì¨¸ò ¾Å¢§Ã¡õ 
 Å¢Æ¢¸ÙìÌï ºÉãýÚ ¿¡ð¦¸¡Ú¸¡ Ä¢Î§Å¡õ 
¿¡Ú¸ó¾õ ÒðÀÁ¢¨Å ¿Î¿º¢Â¢ø Ó¸§Ã¡õ 
 ¿ÁÉ¡÷ì¸¢í §¸Ð¨Å ¿¡Á¢ÕìÌ Á¢¼ò§¾. 
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LITERATURE REVIEW OF MADHUMEGA VIRANAMIN MODERN ASPECT 
 
Diabetes mellitus (DM) is a complex disease affecting almost all the vital organs in 
the body. Diabetic foot is one of the most significant and devastating complication of 
diabetes, foot is affected by ulceration that is associated with neuropathy and peripheral 
arterial disease of the lower limb in a patient with diabetes. 
 
TYPES OF DIABETIC FOOT ULCERS 
Diabetic foot ulcers are divided into 2 groups, namely:   
 
 Neuropathic ulcer Feet is warm; perfusion is still good with pulsation still palpable, 
perspiration is reduced, skin dry and cracked. 
 Neuroischemic ulcer Feet is colder, not palpable pulsation, thin skin, and smooth 
and without hair, subcutaneous tissue atrophy, intermittent claudication and rest pain 
may not be present due to neuropathy. 
 
PATHOPHYSIOLOGY 
The aetiology of a diabetic foot ulcer (DFU) is multifaceted. No single risk factor is 
responsible for a foot ulcer. Several components cause added together to create a sufficient 
impact for ulceration. 
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NEUROPATHY 
 
Peripheral neuropathy (loss of sensation) frequently occurs 20% at the time of 
diagnosis and about 8- 12 years after developing type 2diabetes, and is the permissive factor 
in ulcer development. Diabetic peripheral neuropathy is an impairment of normal activities 
of the nerves throughout the body and can alter autonomic, motor, and sensory functions. 
The reported prevalence of diabetic peripheral neuropathy ranges from 16% to as high as 
66%.More than 60% incidence of foot ulcers caused by Neuropathy and affects patients 
with both type 1 and type 2 DM. The hyperglycemic conditions increased the production of 
some enzyme such as aldose reductase and sorbitol dehydrogenase. These enzymes convert 
glucose into sorbitol and fructose. As these sugar products accumulate, the synthesis of 
nerve cell myo inositol is decreased, affecting nerve conduction. Further, hyperglycemia-
induced microangiopathy conducts the reversible metabolic, motor and sensory nerves, 
immunologic and ischemic injury of autonomic. It induces low peripheral sensation and 
compensation fine vasomotor control of the pedal circulation and the nerve innervations of 
small muscles of the foot. When the nerve gains hurt, the patient is at a high risk of a minor 
injury without spotting it until it makes an ulcer. The sensory loss is increased up to seven-
fold, oppose to non-neuropathic patients with diabetes. DM also influences leading to 
dryness and fissuring of skin, making it prone to infection, the autonomic nervous system. 
The microcirculation of skin is controlled by the autonomic system. These changes assist in 
the expansion of gangrene, ulcers, and limb loss.  
 
CHARCOT NEUROARTHROPATHY  
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VASCULOPATHY 
 
Hyperglycemia causes endothelial cell dysfunction and smooth cell abnormalities in 
peripheral arteries. Endothelial dysfunction is the most serious impairment affecting 
microcirculation, owing to changes in the proliferation of endothelial cells, thickening of the 
basement membrane, decreased synthesis of nitric oxide, increased blood viscosity, 
alterations in micro vascular tone and decreased blood flow. Nitric oxide is synthesized by 
endothelial cells which influence vasodilation and secure the blood vessels from the 
endogenous wound. Accordingly, in hyperglycemia, perturbation of the physiological 
properties of nitric oxide usually anticoagulation regulates the endothelial homeostasis, 
smooth muscle cell proliferation and antioxidant capacity, leukocyte adhesion. 
Endothelium-derived vasodilators and nitric oxide decreased. It leads to the propensity for 
atherosclerosis, constriction of the blood vessels and eventually leading to ischemia. 
Ischemia also happens, in fact, the attendance of palpable pedal pulses. The 
microcirculation is also disturbed due to arteriolar-venular shunting, reducing the blood 
circulation to the area of need. Hyperglycemia in DM also associated with an increase in 
thromboxane A2 leading to plasma hypercoagulability.  
 
IMMUNOPATHY 
 
The immune system of a patient with diabetes is much weaker than the healthy 
people. Thus, foot infection in a patient with diabetes is a limb-threatening and debilitating 
condition. The hyperglycemic state causes an elevation of pro-inflammatory cytokines and 
impairment of polymorph nuclear cell functions like chemo taxis, adherence, phagocytosis 
and intracellular killing.The immune system is compromised by lowered leukocyte activity, 
inappropriate inflammatory response and the disruption of cellular immunity (inhibition of 
fibroblast proliferation and impairment of the basal layer of keratinocytes, reducing 
epidermal cell migration).Leukocyte phagocytosis was significantly reduced in patients with 
poorly controlled diabetes, and improvement of microbiocidal rates was directly correlated 
with correction of hyperglycemia. Decreased chemo taxis of growth actors and cytokines, 
coupled with an excess of metalloproteinase, impede normal wound healing by creating a 
prolonged inflammatory state. This metabolic dysfunction impairs the synthesis of proteins, 
fibroblasts, and collagen, and further systemic deficiencies are propagated which lead to 
nutritional compromise. Research indicates impairment of the immune system with serum 
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glucoselevels ≥150 ml/dl. Patients with diabetes tolerate infection poorly and infection 
adversely affects diabetic control. High blood glucose is a good medium for the growth of 
bacteria, mainly aerobic gram-positive cocci like S. Aureus and β-hemolytic streptococci 
but in one research conducted in India, gram-negative aerobes were the common 
microorganisms in the diabetic foot. Muscles sheaths, tendons, the soft tissues of foot like 
plantar aponeurosis, and fascia cannot resist infections. 
 
 
 
MECHANICAL STRESS 
 
In people with neuropathy, minor trauma (e.g. from ill-fitting shoes, walking 
barefoot or an acute injury) can precipitate ulceration of the foot. Loss of sensation, foot 
deformities, and limited joint mobility can result in abnormal biomechanical loading of the 
foot. This produces a high pressure in some areas, to which the body responds with 
thickened skin (callus).Usually, ulcers happen in the plantar of great toe and heel and 
unfitting shoes (which are the source of trauma) can cause ulcers on the dorsal aspect. 
Hence neuropathic foot ulcer formation in patients with diabetes has a complex 
multifactorial aetiopathogenesis wherein areas of high pressure complimented by peripheral 
neuropathy and associated skin changes lead to ulcer formation. 
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NEUROARTHROPATHY 
 
A chronic painless progressive degenerative arthropathy is popular as Charcot 
neuroarthropathy (CN) resulting from the disruption in sensory innervations of the affected 
joint. Charcot foot is an insidious, destructive, and progressive pathological condition that 
affects the foot bones and leads to a deformity that may cause ulcer formation and 
subsequent disability. The development of Charcot's foot is characterized by subluxation 
and joint dislocation, osteolysis and bone fragmentation, and soft tissue edema. The 
demolition of the autonomic nervous system because of DM causes an upgrade in local 
blood provides and the resting blood flow is higher than in the normal patient. The 
incidental elevated in blood flow due to calcium to dissolve, leading the osteoclastic activity 
of the bone and damaging the bone. Another theory is that the repeated small trauma to the 
insensate joints conducts to fracture and disintegration. The pro-inflammatory cytokines 
production conducts to uncontrolled osteolysis in CN.  
 
 
 
The cytokines like tumor necrosis factor-α and interleukin-1β increase the expression of 
receptor activator of nuclear factor-κb (RANKL), which in turn makes maturation of 
osteoclasts by causing the production of nuclear factor-κb. The hallmark deformity 
associated with this condition is a midfoot decay, also known as “rocker-bottom” foot. 
There might be hallux valgus 
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Deformity and lose bodies in the joint cavity. The deformities connected with CN also 
predispose to recurrent ulcerations. 
 
 
 
EPIDEMIOLOGY 
 
In people with diabetes, and is the most important precursor for lower-extremity 
amputations. By 2015 prevalence data from the International Diabetes Federation; it 
estimated that, annually, foot ulcers develop in 9.1 million to 26.1 million people with 
diabetes worldwide.  
 
CLASSIFICATION 
 
There are many classifications of the diabetic foot. However, the most commonly 
used classification systems are the Wagner-Ulcer Classification system and the University 
of Texas Wound 
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CAUSES: 
 Poor blood circulation 
 High blood sugar level 
 Nerve damage 
 Minor trauma 
 
CLINICAL FEATURES: 
 
 Swelling, discoloration, and warmth around the wound 
 Foul-smell discharge from the wound 
 Pain and firmness when the wound is touched 
 Callus or thickened skin present around the ulcer 
 Fever and chills in advanced stage of foot ulcer 
 Painless ulcer or only mildly painful unilateral swelling of ulcer 
 Paresthesia 
 Cellulitis 
 Osteomyelitis 
 Gangrene and amputation. 
 
RISK FACTOR: 
 
Previous studies have identified smoking as a risk factor for diabetic foot ulcers 
because daily tissue hypoxia may cause vascular and neuropathic disorders in the lower 
extremities of diabetic patients.The contribution of obesity to the risk of diabetic foot 
ulceration is inconclusive. Previous studies have revealed that obesity might associate with 
diabetic foot ulcers. However; there are also prospective studies showing that BMI has no 
significant correlation with a diabetic foot ulcer. Zang et al. in their study suggested that 
patients with diabetic foot ulceration had lower BMIs than patients without a diabetic foot, 
and most BMI levels in our study ranged from 25 to 30 kg/m2. These results suggested that 
the association between BMI ranging from 25 to 30 kg/m2 and diabetic foot ulcer requires 
further research. Their study also suggested that diabetic foot was more common in male 
diabetic patients than female patients. One explanation of this gender difference might be 
the involvement in increased physical work in males 
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TREATMENT 
 
The gold standard for diabetic foot ulcer treatment includes debridement of the 
wound, management of any infection, revascularization procedures when indicated, and off-
loading of the ulcer. Other methods have also been suggested to be beneficial as add-on 
therapies, such as hyperbaric oxygen therapy, use of advanced wound care products, and 
negative pressure wound therapy (NPWT). 
 
Negative-Pressure Wound Therapy 
 
Negative-pressure wound therapy (NPWT) has emerged as a new treatment for 
diabetic footulcers. It involves the use of intermittent or continuous sub atmospheric 
pressure through a special pump (vacuum-assisted closure) connected to a resilient open-
celled foam surface dressing covered with an adhesive drape to maintain a closed 
environment. The pump is connected to a canister to collect wound discharge and exudate. 
Experimental data suggest that NPWT optimizes blood flow, decreases tissue edema, and 
removes exudate, pro inflammatory cytokines, and bacteria from the wound area. It should 
be performed after debridement and continued until the formation of healthy granulation 
tissue at the surface of the ulcer. Currently, NPWT is indicated for complex diabetic foot 
wounds; however, it is contraindicated for patients with an active bleeding ulcer. Two small 
studies and one larger study provide some encouraging data concerning the possible benefit 
of NPWT in the healing rate and time of diabetic foot ulcers. However, more randomized 
trials are needed in order to confirm these results. 
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Hyperbaric Oxygen 
 
There is strong evidence that fibroblasts, endothelial cells, and keratinocytes are 
replicated at higher rates in an oxygen-rich environment. Moreover, leukocytes kill bacteria 
more effectively when supplied by oxygen. It is also known that fibroblasts from diabetic 
individuals show diminished cell turn over in comparison with those from non-diabetic 
persons. Based on these data, the idea was that the administration of oxygen at high 
concentrations might accelerate wound healing in diabetes. Treatment with hyperbaric 
oxygen therapy involves the intermittent administration of 100% oxygen at a pressure 
greater than that at sea level. It is performed in a chamber with the patient breathing 100% 
oxygen intermittently while the atmospheric pressure is increased to 2–3 atmospheres for 
duration of 1–2 h.  
 
PREVENTION: 
 Special foot care to prevent foot ulcer to poor 
 Patients should not walk around barefoot, but use proper foot wears. 
 Control blood sugar level. 
 
DIABETIC FOOT CARE: 
 Inspect your feet daily 
 Wash your feet in luke warm 
 Make sure to carefully dry between the toes 
 Moisture your feet but not between your toes 
 Never cut corns or callus 
 Wear clean and dry socks 
 Never walk in barefoot. Not even at home 
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DRUG REVIEW 
 
INTERNAL MEDICINE 
GANDHI MATHIRAI 
Gandhagam (Sulphur)   
Kaatupagal (Momorandica dioica)     
Karunai kizhangu (Typhonium trilobatum)    
Kadukai (Terminalia chebula)  
Sembai (Sesbania sesban)   
 
GANTHAGAM 
English name  :  Sulphur 
 
Organoleptic character 
Taste   :  Kaippu, Thuvarpu 
Potency  :  Veppam, Thatpam 
 
¦À¡Ð Ì½õ: 
''¦¿øÄ¢ì¸¡öì¸ó¾¢ìÌ¿£û À¾¢¦ÉñÌð¼Áó¾õ 
Åø¨Ä¸Å¢¨º ÌýÁ Å¡Ô¸ñ§½¡ö-¦À¡øÄ¡ 
Å¢¼ì¸Ê Åý§Á¸§É¡ö Å£ÚÍÃõ§À¾¢ 
¾¢ì¸¢ÃÍ½£¸Àõ§À¡ó§¾÷'' 
 
ACTION: 
 
 Laxative 
 Tonic 
 Antiseptic 
 Diaphoretic 
 Cholagogue 
 
KAATUPAGAL 
Botanical name :   Momordica dioica 
Family  :  Cucurbitaceae 
Parts used  :  Fruit 
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Organoleptic characters 
Taste    :   Bitter 
Potency  :   Hot 
Division  :   Pungent 
 
ACTION  
 Astringent 
 Stimulant  
 Expectorant   
 
CHEMICAL CONSTITUENTS 
 
Calcium, iron, zinc, manganese, iodine, chromium, phytic acid, total phenolic 
compound, alkaloids, flavonoids, steroids, triterpinoids, saponins.  
 
PHARMACOLOGICAL ACTIVITY  
 Wound healing activity 
 Anti-microbial activity 
 Anti-diabetic activity 
 Anti-oxidant activity 
 Analgesic activity 
 Neuro protective 
 Anti-cancer 
 Immunomodulator 
 Anti lipidemic 
 
The antioxidant activities of methanol and aqueous extract of fruits were analyzed and 
the presence of phenolic compounds, flavonoids, sterol, alkaloids, amino acids, and so forth, 
were found. Among those compounds, due to the presence of flavonoids, its fruit was 
reported as a potent antioxidant.Anti-diabetic specifically oral hypoglycemic effects 
of Momordica dioica in rat model was screened by Fernandopulle et al.Gupta et al. 
investigated the antidiabetic and renal protective effect of Momordica dioica methanolic 
extract (MDMtE) in streptozotocin-treated diabetic rats. Evaluated hexane and methanolic 
extract of fruit pulp mediated, anti-inflammatory activities. 
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KARUNAI KIZHANGU  
Botanical name :   Typhonium trilobatum 
Family  :   Araceae 
Parts used  :   Rhizome 
 
Organoleptic characters 
Taste    :   Pungent 
Potency  :   Hot 
Division  :   Pungent 
ACTION: 
 Stimulant 
 Astringent  
 
CHEMICAL CONSTITUENTS: 
  
The root contain proteins and inorganic substance Ca, P, I, Fe, Na, K; thiamine, 
niacin, carotene, folic acid sterols and beta sitosterol. 
 
PHARMACOLOGICAL ACTIVITY: 
 Wound healing activity 
 Anti-oxidant activity 
 Anti-inflammatory 
 Anti-depressant 
 Thrombolytic activity 
 
Ethanol extract of Typhonium trilobatum roots has antioxidant activity. The thrombolytic 
activity of the Typhonium trilobatum root extracts were carried out using a simple and rapid 
in vitro clot lysis model.Xylene-induced ear edema in rats was used to assess anti-
inflammatory activity of the plant extract.The ethanolic leaf extract of T.  trilobatum was 
shows analgesic activity using acetic acid-induced writhing method. 
 
KADUKKAI 
Botanical name :   Terminalia chebula 
Family  :   Combretaceae 
Parts used  :   Fruit 
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Organoleptic characters 
Taste   :   Pungent 
Potency :   Hot 
Division :   Sweet 
 
¦À¡Ð Ì½õ 
¾¡¨¼ ¸Øò¾ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
À£¨¼ º¢Ä¢À¾Ó¾ü §À¾¢Ó¼õ-¬¨¼¦Âð¼¡ò 
àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø 
 
ACTION: 
 Astringent  
 Alterative  
 Purgative 
 
CHEMICAL CONSTITUENTS: 
 
Chebulic acid, palmitic acid, stearic acid, oleic acid, linoleic acid and anthroquinone 
derivatives, tannic acid, gallic acid. 
 
PHARMACOLOGICAL ACTIVITY: 
 
 Antibacterial 
 Antifungal 
 Antiviral  
 Anti-Carcinogenic 
 Antioxidant 
 Hypolipidemic 
 Hepatoprotective 
 Cardio Protective 
 Anti-Diabetic 
 Wound healing activities 
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The extract of Terminalia chebula shows broad spectrum activitiy.ethanolic 
extract of Terminalia chebula showed antimicrobial activity against methicillin-
resistant Staphylococcus aureus It has stronger antioxidant activity than alpha-
tocopherol. HPLC analysis with diode array detection indicated the presence of 
hydroxybenzoic acid derivatives, hydroxycinnamic acid derivatives, flavonol 
aglycones and their glycosides, as main phenolic compounds.The chloroform extract 
of Terminalia chebula seeds produced dose-dependent reduction in blood 
glucose of diabetic rats compared with standard drug glibenclamide in both short and 
long term study T. chebula  showed improvement to stimulate fibroblast function, 
enhance synthesis of glycoseminoglycans and deposition of collagen. Thus, it offers 
a distinct advantage to wound healing. 
 
SEMBAI 
 
Botanical name :  Sesbania sesban 
Family  :  Fabaceae  
Parts used  :  Leaf 
 
Organoleptic characters 
Taste    :  Bitter 
Potency  :  Hot 
Division  :  Pungent 
 
ACTION: 
 Stimulant 
 Astringent 
 Expectorant  
 
CHEMICAL CONSTITUENTS: 
 
Oleanolic acid, beta-D-galactopyranoside,saponin,anthocyanidins.triterpenoids, 
starches, vitamins, amino acids, proteins, tannins, saponins glycosides and steroids. 
Blossoms contain cyanidin and delphinidinglucosides ,Alpha-ketoglutaric, oxaloacetic and 
pyruvic acids. Leaf and unit contains ampesterol cholesterol, beta-sitosterol, triterpenoids, 
proteins and tannins. Bark and stem contains glucose, fructose, erithryrol, arabinitol, myo-
inositol.  
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PHARMACOLOGICAL ACTIVITY: 
 Anti-oxidant 
 Anti-inflammatory 
 Anti-diabetic 
 Wound healing activity 
 
The antioxidant activity of the Sesbania sesban  acidified methanol extract showed 
high scavenging activity of 84% at lower concen-tration (1mg) along with the standard 
BHT (37.65%) and Ascorbic acid is considered as the positive control. The aqueous leaves 
extract of Sesbania sesban was evaluated for its antidiabetic potential on normal and 
streptozotocin (STZ)-induced diabetic rats. Anthocyanins from Sesbania sesban flower 
petals exhibited a dose dependent free-radical scavenging activity against DPPH radical, 
superoxide anions and hydroxyl radical. 
 
External medicine 
SAGALA RANAGALUKUM KALIMBU: 
  Lingam(Cinnabar) 
  Miruthar singi(Lead Ore) 
  Rasakarpooram(Calomel) 
  Vellai kungiliyam(Vateria indica) 
  Kadukkai(Terminalia chebula) 
  Masikkai(Quercus infectoria) 
  Thandrikkai(Terminalia bellerica) 
  Kaichukkatti(Catechu) 
 
LINGAM 
English name : cinnabar  
¦À¡Ð Ì½õ: 
''§À¾¢ÍÃï ºó¿¢ ¦ÀÕÅ¢Ã½ ¿£¦Ã¡Î¾ 
¸¡¾¸Ê ¸¡ºí ¸ÃôÀ¡ýÒñ-§½¡¾ 
×ÕÅ¢Ä¢í¸ ºí¸¾Á¡ äÚ¸ðÊ Ôõ§À¡í 
ÌÕÅ¢Ä¢í¸ ºí¸Áò¨¾ì ¦¸¡û.'' 
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ACTION 
 Alterative 
 
INDICATION: 
 Chronic non healing ulcer 
 Skin diseases 
 Arthritis 
 Diarrhea 
 Fever 
 Frequency of micturition 
 Eczema 
 Cough 
 
MIRUTHAR SINGI 
 
English name : Lead Ore 
 
¦À¡Ð Ì½õ: 
''Á¢Õ¾¡Ã º¢í¦¸É§Å ¦ÁøÄ×¨Ãò¾¡Öõ 
ÓÕÅ¡÷ Ò¨¼¸ÃôÀ¡ §É¡Î-¦Á¡ÕÅ¢¾§Á¡ 
º¡Äî º¢ÃíÌÒñßó ¾ôÀ¡Á Ä¡È¢Å¢Î\ 
§Å¦Ä¡ò¾ ¸ñÁÂ¢§Ä Å¢û'' 
 
ACTION: 
 Astringent 
 Refrigerant 
 Anthelmintic 
 
TYPE: 
 It has three types there are Miruthar Singi, Raththa Singi,Aema Singi 
INDICATION: 
 Chronic skin diseases 
 Chronic ulcer 
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RASAKARPOORAM 
 
English name   :  Calomel 
 
¦À¡Ð Ì½õ 
''þ¨¼Å¡¾ Ý¨Ä ¦ÂÃ¢Ý¨Ä ÌýÁó 
¦¾¡¨¼Å¡¨Æ Å¡¾Á¡ï §º¡½¢-Â¢¨¼Â¡§¾¡ 
¦Å¡ì¸Ãº ¸÷ôâÃ ¦Á¡ý§È ÂÇ¦Å¡Î¿ø 
þìÌ¦ÅøÄò §¾Ø¿¡ Ç£.'' 
 
Organoleptic characters 
 
Taste   :  Salt, Pungent 
Potency :  Hot 
Division :  Pungent  
 
INDICATION 
 Low back pain 
 Gastric ulcer 
 Chronic non healing ulcer 
 Sinusitis 
 Arthritis 
 Diabetes 
 Constipation 
 Head ache 
 
VELLAI KUNGILIYAM 
 
Botanical name :  Vateria indica 
Family  :  Dipterocarpaceae 
Parts used  :  Resin 
 
Organoleptic characters 
Taste    :  Bitter 
Potency  :  Hot 
Division  : Pungent 
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ACTION: 
 Stimulant 
 Diuretic 
 Expectorant 
 
¦À¡Ð Ì½õ 
¦Åû¨Ç ÂÇ¢ò¾ Å¢Ã½¿¡ À¢ì¸ÁÄò 
¦¾¡û¨ÇÅ¢Ã ½õ§Á¸ó §¾¡üÚ¸¢Ûõ-¯û§Ç 
ÅÕÅÃº¨É§ÁüÒñ ÅÃ¢Ûõï Í§Å¾î 
ºÕÅÃº §ÁüÀÆ¢¨Âî º¡üÚ. - §¾¨ÃÂ÷ Ì½Å¡¸¼õ 
 
INDICATION: 
 Cystitis 
 Fissure in ano 
 Internal hemorrhoids 
 Ulcer 
 
CHEMICAL CONSTITUENTS 
Resin is a complex mixture of several triterpene hydrocarbons, ketones, alcohols and 
acids, along with small amounts of sesquiterpenes. 
 
PHARMACOLOGICAL ACTIVITY 
 Anti-inflammatory 
 Anti tumour activity 
 Anti-microbial activity 
 
Vateria indica leaves have anti-inflammatory activity which may be due to the 
presence of alkaloids, steroids and glycosides. 
 
KADUKKAI 
Botanical name : Terminalia chebula 
Family  : Combretaceae 
Parts used  : Fruit 
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¦À¡Ð Ì½õ 
¾¡¨¼ ¸Øò¾ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
À£¨¼ º¢Ä¢À¾Ó¾ü §À¾¢Ó¼õ-¬¨¼¦Âð¼¡ò 
àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø 
Organoleptic characters 
Taste   : Pungent 
Potency : Hot 
Division : sweet 
 
ACTION: 
 Astringent  
 Alterative  
 Purgative 
 
CHEMICAL CONSTITUENTS: 
 
Chebulic acid, palmitic acid, stearic acid, oleic acid, linoleic acid and anthroquinone 
derivatives, tannic acid, gallic acid. 
 
PHARMACOLOGICAL ACTIVITY: 
 Antibacterial 
 Antifungal 
 Antiviral  
 Anti-Carcinogenic 
 Antioxidant 
 Hypolipidemic 
 Hepatoprotective 
 Cardio Protective 
 Anti-Diabetic 
 Wound healing activities 
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The extract of Terminalia chebula shows broad spectrum activitiy.ethanolic 
extract of Terminalia chebula showed antimicrobial activity against methicillin-
resistant Staphylococcus aureus It has stronger antioxidant activity than alpha-
tocopherol. HPLC analysis with diode array detection indicated the presence of 
hydroxybenzoic acid derivatives, hydroxycinnamic acid derivatives, flavonol 
aglycones and their glycosides, as main phenolic compounds.The chloroform extract 
of Terminalia chebula seeds produced dose-dependent reduction in blood 
glucose of diabetic rats compared with standard drug glibenclamide in both short and 
long term study T. chebula  showed improvement to stimulate fibroblast function, 
enhance synthesis of glycoseminoglycans and deposition of collagen. Thus, it offers 
a distinct advantage to wound healing. 
 
MASIKKAI 
 
Botanical name :  Quercus infectoria 
English name  :  Magic nuts 
Family  :  Fagaceae 
Parts used  : Galls, bark 
 
¦À¡Ð Ì½õ 
«ì¸Ãí¸û §À¡ì¸¢Å¢Îõ Á¡È¡¾ ¦ÅôÀ¸üÚõ 
¦ÁöìÌÚ¾¢ Á¡º¢ì¸¡ö ¦Áý§ÁÖõ-¾ì¸¦¾¡Õ 
À¡Ä÷¸½ §¿¡ö§À¡ìÌõ Àý§Á¸ Óó¦¾¡¨ÄìÌõ 
§ÅÄ¨ÉÂ ¸ñ½ö Å¢Ç¢õÒ. - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
 
ACTION: 
 Astringent  
 Alterative  
 Hemostatic 
 Tonic 
 
CHEMICAL CONSTITUENTS: 
  Tannic acid,2-4% gallic acid, ellagic acid,sugar,starch,gallo tannic acid,50-70% 
tannin. 
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PHARMACOLOGICAL ACTIVITY: 
 
Quercus infectoria antibacterial activity was quite good, Proteus vulgaris showed 
very good results (20 mm) of MIC & minimum of Enterobacter aerogenes. The antioxidant 
activity of Quercus infectoria in methanolic extract using DPPH assay method shows 
appreciable activity comparable to standard ascorbic acid. The wound healing and repair is 
accelerated by applying Quercus infectoria which was high-lighted by the full thickness 
coverage of the wound area by an organized epidermis in the presence of mature scar tissue 
in the dermis. 
 
THAANDRIKKAI 
Botanical name :  Terminalia bellerica 
English name  :  Belleric myrobalan 
Family  :  Combretaceae 
Parts used  :  Fruit,bark 
 
¦À¡Ð Ì½õ 
º¢Äó¾¢ Å¢¼õ ¸¡Á¢Âõô Òñ º£Æ¡É §Á¸í 
¸ÄóÐÅÕõ Å¡¾À¢ò¾í ¸¡§Ä¡-¼Ä÷óÐ¼Ä¢ø 
°ýÈ¢ì¸¡ö ¦ÅôÀ Ó¾¢ÃÀ¢ò Ðí¸ÃìÌó 
¾¡ýÈ¢ì¸¡ö ¨¸Â¢¦ÄÎò ¾¡ø 
 
ACTION: 
 Astringent 
 Expectorant 
 Laxative 
 Tonic  
 
PHARMACOLOGICAL ACTIVITY 
 Anti-oxidant 
 Anti-inflammatory 
 Wound healing 
 Anti-microbial 
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Ramesh Kumar et al demonstrated that in vitro assessment of the antioxidant activity of 
ethanolic fractions of Terminalia bellerica to scavenge 2, 2- Diphenyl-1-picrylhydrazyl 
(DPPH) and highly reactive hydroxyl radicals showed that the semi pure compounds 
present in the fractions are useful potential source of antioxidants.25 . M.C.Babu et al; 
demonstrated that administration of T. belerica extract did not have any significant effect on 
serum glucose level in alloxan diabetic rats during first five days but started reducing from 
6
th
 day onwards .On 9
th
 day when compared with that of control diabetic animals serum 
glucose in extract treated animals was found to be reduced to 54% .  
 
KAAICHUKATTI 
Botanical name : Arecha catechu 
Family  : Palmaeae 
Parts used  : Seed, extract, root, leaves 
 
¦À¡Ð Ì½õ 
¸Ç¢ôÀ¡ìÌò ¾¢ýÈì¸¡ü ¸ñ¼Ðð §¸¡¨Æ 
¦Â¡Ç¢ôÀ¡À¡¸ì ¸ðÎÁ¢·Ðñ¨Á-¾Ç¢÷ôÀ¡É 
À¢ò¾ «§Ã¡º¸õ §À¡õ §À¾¢Á¢¸ ¯ñ¼¡Ìï 
º¢ò¾ Á¸¢úîº¢ÔÚï ¦ºôÒ.  - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
ACTION: 
 Stimulant 
 Astringent 
 Toenifuge 
 
PHARMACOLOGICAL ACTIVITY 
 Anti-inflammatory activity 
 Anti-oxidant 
 Anti-diabetic 
 Anti-microbial 
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Chempakam B et al;has reported that arecoline a major constituent of Areca catechu 
havehypoglycaemic activity in an animal model of diabetes upon subcutaneous 
administration. The Subcutaneous administration of alkaloid fraction of Areca catechu 
(0.05_/0.5 mg/kg) in alloxanized rabbits (140 mg/kg) showed significant hypoglycaemic 
effect lasting for 4/6 hours 9. Inokuchi J, Okabe H et al describes that Areca tannin inhibits 
the pressure response angiotensin I and II thus showing a regulatory effect on blood 
pressure. 
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MATERIALS AND METHODS  
 
COLLECTION OF RAW DRUGS:  
The required raw drugs for the preparation of the trial medicines were collected 
from a well reputed country raw drug shop.  
 
RAW DRUGS IDENTIFICATION AND AUTHENTICATION: 
 
The mineral raw drugs were identified and authenticated by Dr.visweshwaran 
M.D(s), Lecturer, Department of Gunapadam,National institute of siddha 
NIS/GUNAPADAM/ AU/ 2017/4. The Herbal raw drugs were identified and authenticated 
by Dr.D.Aravind M.D(s), Assistant professor, Dept. of Botany, National Institute of Siddha, 
Certificate no NISMB2892017. After that the raw drugs were purified as per siddha 
literature then the trial drugs prepared in Gunapadam laboratory of National Institute of 
Siddha. 
 
INTERNAL DRUG: 
GANDHI MATHIRAI: 
INGREDIENTS OF GANDHI MATHIRAI: 
Gandhgam   (Sulphur)    
Kaatupagal  (Momorandica dioica)     
Karunai kizhangu (Typhonium trilobatum)    
Kadukai  (Terminalia chebula)    
Sembai ilia charu  (Sesbania sesban) 
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RAW DRUGS OF GANDHI MATHIRAI 
 
  SULPHUR                                Terminalia chebula 
  
  
 
 
   Momordica dioica                                     Sesbania seaban 
 
 
               Typhonium trilobatum 
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METHOD OF PURIFICATION OF RAW DRUGS: 
Purification of Gandhagam (Sulphur): 
 
 Sulphur is placed in an iron spoon. A small quantity of cow‟s butter is added and 
the spoon is heated till the butter melts; this mixture is immersed in inclined position in 
cow‟s milk. This procedure is repeated for 30 times to get purified sulphur. Each time, fresh 
milk is to be used. [Ref: Siddha Materia Medica (Mineral and animal kingdom) Page No: 
253] 
 
Purification of kadukkai (Terminalia chebula): 
Remove the nut and use the outer covering of the drug.[Ref- Sarakugalin  suthi  
muraigal  pg.no  4] 
 
METHOD OF PREPARATION : 
Gandhgam  (Sulphur)    
Kaatupagal  (Momorandica dioica)     
Karunai kizhangu (Typhonium trilobatum)    
Kadukai  (Terminalia chebula)    
Sembai ilia charu (Sesbania sesban) 
The above raw drugs will be ground with sembai leaf juice and made into 65mg pills. 
 
GANDHI MATHIRAI 
 
Dose: Ulunthalvu (65mg) 
Vehicle: Thirikadugu Chooranam 
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Indication: 
Pun(DiabeticUlcer),13vagaisanni(Delirium),Swasakasam(Bronchitis),Kirani(Diarr
hoea),vaayu(Gastritis),7 Vagai kasam(Cough),Vadham(Pain), Pandu(Anemia),18 Vagai 
Kuttam(Skin Diseases). 
 
EXTERNAL MEDICINE: 
SAGALA RANAGALUKUM KALIMBU 
INGREDIENTS OF SAGALA RANAGALUKUM KALIMBU: 
 
 Lingam (Cinnabar) 
 Miruthar singi (Lead ore) 
 Rasakarpooram (Calomel) 
 Vellai kungiliyam (Vateria indica) 
 Kadukkai (Terminalia chebula) 
 Masikkai (Quercus infectoria) 
 Thandrikkai (Terminalia bellerica) 
 Kaichukkatti (Catechu) 
 
LINGAM     RASAKARPOORAM 
 
MIRUTHAR SINGI     KAICHUKKATTI 
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KADUKKAI      MASIKKAI 
 
 
THANDRIKKAI                  VELLAIKUNGILIYAM            
 
 
 
 
 
 
 
 
 
 BUTTER 
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METHOD OF PURIFICATION OF RAW DRUGS 
Purification of kadukkai (Terminalia chebula): 
Remove the nut and use the outer covering of the drug.[Ref- Sarakugalin  suthi  muraigal  
pg.no  4] 
 
Purification of Thandrikkai (Terminalia bellerica): 
Remove the nut and use the outer covering of the drug.[Ref- Sarakugalin  suthi  muraigal  
pg.no  7] 
 
Purification of Masikkai(Quercus infectorius): 
Remove the nut and use the outer covering of the drug.[Ref- Sarakugalin  suthi  muraigal  
pg.no  13] 
 
Purification of Lingam(Cinnabar): 
The mineral drug soaked with lime juice for 2 hours.[Ref- Sarakugalin  suthi  muraigal  
pg.no  51] 
 
Purification of Rasakarpooram(Calomel): 
The mineral drug ties in cotton cloth and dipped with the decoction of pepper and betel leaf 
paste and boiled for 3 days [[Ref- Sarakugalin  suthi  muraigal  pg.no53]. 
 
Purification of vellai kungiliyam(Vateria indica): 
The herbal drug soaked with lime juice.  [Ref- Sarakugalin  suthi  muraigal  pg.no  4] 
 
METHOD OF PREPARATION: 
 Miruthar singi  (Lead Ore) 
 Rasakarpooram (Calomel) 
 Vellai kungiliyam (Vateria indica) 
 Kadukkai  (Terminalia chebula) 
 Masikkai  (Quercus infectoria) 
 Thandrikkai  (Terminalia bellerica) 
 Kaichukkatti  (Catechu) 
 
The above mentioned ingredients are taken in equal quantity and made into fine powder. 
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It‟s mixed with sufficient quantity of cow‟s butter and allows the paste into water for 24 hrs. 
SAGALARANAGALUKUM KALIMBU 
 
 
INDICATION :  Kodumeiyana ranangal (Madhumega viranam) 
 
DRUG STORAGE:  
             The trial drug Gandhi mathiraiis stored in clean and dry glass bottles and Sagala 
ranangalukum kalimbuis stored in clean and dry bottles. 
 
 
DISPENSING: 
The tablet is given in packet. Paste is given in zip lock cover.  
 
BIOCHEMICAL ANALYSIS:  
Experimental procedure:  
5 g of Gandhi mathirai was taken in a 250 ml of clean beaker and 50ml of distilled 
water was added to it. Then it was boiled well for about 10 min. Then it is allowed to cool 
and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/ basic radicals and biochemical 
constituents in it. 
 
Preparation of extract:  
5gm of Gandhi mathirai is weighed accurately and placed in a 250ml clean beaker 
and 50ml of distilled water was added with it. Then it was boiled well for about 10 minutes. 
Then it was allowed to cool and filtered in a 100ml volumetric flask and made up to 100ml 
with distilled water. The bio-chemical analysis of Gandhi mathirai was done at 
Biochemistry lab, National Institute of siddha, Chennai-47.  
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Preliminary test for Copper, Sodium, Silicate and Carbonate:  
Test for Silicate:  
A little (500mg) of the sample is shaken well with distilled water. b. A little(500mg) 
of the sample is shaken well with con. HCl/Con.H2So4. Sparingly /completely soluble  
indicates presence of silicate. 
 
Action of Heat:  
 
A small amount (500mg) of the sample is taken in a dry test tube and heated gently 
at first and then strong. Evolution of white fumes/brown fumes indicates presence of 
carbonate. 
 
Flame Test:  
 
A small amount (500mg) of the sample is made into a paste with con.HCl in a watch 
glass and introduced into non-luminous part of the Bunsen flame. Presence of bluish green 
flame indicates the presence of copper. 
 
Ash Test:  
 
A filter paper is soaked into a mixture of sample and dil. cobalt nitrate solution and 
introduced into the Bunsen flame and ignited. Presence of yellow color flames indicates the 
presence of sodium. 
 
Test for Acid Radicals  
 
Test for Sulphate:  
2ml of the above prepared extract was taken in a test tube and 2ml of 4% dil. 
ammonium oxalate solution was added. Evolution cloudy appearance it indicates presence 
of sulphate. 
 
Test for Chloride:  
2ml of the above prepared extracts was added with 2ml of dil-HNO3 until the 
effervescence ceases off. Then 2 ml of silver nitrate solution was added. Presence of cloudy 
appearance indicates the presence of chloride. 
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Test for Phosphate:  
2ml of the extract was treated with 2ml of con.HNo3 and 2ml of dil. ammonium 
molybdate solution. Evolution cloudy yellow appearance it indicates presence of phosphate. 
 
Test for Carbonate:  
2ml of the extract was treated with 2ml dil. magnesium sulphate solution.Evolution cloudy 
appearance it indicates presence of carbonate. 
 
Test for Nitrate: 
1gm of the substance was heated with copper turning and concentrated H2SO4 and 
viewed the test tube vertically down. Evolution of brown gas indicates presence of nitrate. 
 
Test for Sulphide:  
1gm of the substance was treated with 2ml of con. HCL. Evolution of rotten egg 
smell indicates the presence of sulphide. 
 
Test for Fluoride & Oxalate:  
 
2ml of extract was added with 2ml of dil. Acetic acid and 2ml dil.calcium chloride 
solution and heated. Evolution of cloudy appearance indicates the presence of fluride and 
oxalate. 
 
TEST FOR BASIC RADICALS  
Test for Lead:  
 
2ml of the extract was added with 2ml of dil. potassium iodine solution. Presence of 
yellow precipitate indicates the presence of lead. 
 
Test for Copper:  
One pinch (50mg) of substance was made into paste with con. HCl in a watch glass 
and introduced into the non-luminous part of the flame. Presence of blue colour flame 
indicates the presence of copper. 
 
Test for Aluminium:  
In the 2ml of extract dil. sodium hydroxide was added in 5 drops to excess. A mild 
characteristic change seen indicates the presence of aluminium.  
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Test for Iron:  
a. a.To the 2ml of extract add 2ml of dil. ammonium solution.mild red colour 
appearance indicates the presence of iron. 
 
b. To the 2ml of extract 2ml thiocyanate solution and 2ml of con HNo3 is added. 
Presence of blood red indicates presence of iron. 
 
Test for Zinc:  
In 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess 
and dil.ammonium chloride was added. Appearance of white precipitate indicates the 
presence of zinc. 
 
Test for Calcium:  
2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution. 
Evolution of cloudy appearance indicates the presence of calcium. 
 
Test for Magnesium:  
In 2ml of extract dil.sodium hydroxide solution was added in drops toexcess. If the 
white precipitate is obtained indicates presence of magnesium. 
 
Test for Ammonium:  
In 2ml of extract 1 ml of Nessler's reagent and excess of dil. sodium hydroxide 
solution were added. Evolution of brown colour indicates the presence of ammonium. 
 
Test for Potassium: 
A pinch (25mg) of substance was treated with 2ml of dil. sodium nitrite solution and 
then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic acid. Appearance of 
yellowish precipitate indicates the presence of potassium. 
 
Test for Sodium:  
2 pinches (50mg) of the substance was made into paste by using HCl and introduced 
into the blue flame of Bunsen burner. Appearance of yellow colour indicates the presence of 
sodium. 
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Test for Mercury:  
2ml of the extract was treated with 2ml of dil. sodium hydroxide solution. 
Appearance of yellowish precipitate indicates the presence of mercury. 
 
Test for Arsenic:  
2ml of the extract was treated with 2ml of dil. sodium hydroxide solution.  
Appearance of brownish precipitate indicates the presence of arsenic. 
 
OTHER CONSTITUENTS  
 
Test for Starch:  
2ml of extract was treated with weak dil. iodine solution. Evolution of blue color 
indicates presence of starch. 
 
Test for Reducing Sugar:  
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 
2 minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. Evolution 
of brick red colour indicates the presence of reducing sugar. 
 
Test for the Alkaloids:  
a. 2ml of the extract is treated with 2ml of dil. potassium iodide solution. Evolution of 
red color indicates the presence of alkaloid.  
b. 2ml of the extract is treated with 2ml of dil.picric acid. Evolution of yellow colour 
indicates the presence of alkaloid. 
 
Test for Tannic Acid:  
2ml of extract was treated with 2ml of dil. ferric chloride solution. Appearance of 
black precipitate indicates the presence of tannic acid. 
 
Test for Amino Acid:  
2 drops of the extract was placed on a filter paper and dried well, and then 20ml of 
Burette reagent was added in it. Appreaence of violet colour indicates the presence of amino 
acid. 
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Test for Types of compound: 
2ml of the extract is treated with 2ml of ferric chloride solution.  Appearance of 
green color indicates the presence of oxy quinole epinephrine and pyrocatechol. 
 
PHYTOCHEMICAL ANALYSIS 
Test for alkaloids: 
 
Mayer's Test: To the test sample, 2ml of mayer's reagent was added, a dull white 
precipitate revealed the presence of alkaloids. 
 
Test for coumarins:  
To the test sample, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow color. 
 
Test for saponins:  
       To the test sample, 5 ml of water was added and the tube was shaken vigorously. 
Copious lather formation indicates the presence of Saponins. 
 
Test for tannins:  
       To the test sample, ferric chloride was added, formation of a dark blue or greenish 
black color showed the presence of tannins. 
 
Test for glycosides- Borntrager‟s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water 
bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated and 
10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
 
Test for flavonoids: 
To the test sample about 5 ml of dilute ammonia solution were been added followed 
by addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates the 
presence of Flavonoids. 
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Test for phenols: 
Lead acetate test:  
To the test sample; 3 ml of 10% lead acetate solution was added.  A bulky white 
precipitate indicated the presence of phenolic compounds. 
 
Test for steroids: 
To the test sample, 2ml of chloroform was added with few drops of conc. Sulphuric 
acid (3ml), and shaken well. The upper layer in the test tube was turns into red and 
sulphuric acid layer showed yellow with green fluorescence. It showed the presence of 
steroids. 
 
Triterpenoids  
Liebermann–Burchard test: To the chloroform solution, few drops of acetic 
anhydride was added then mixed well. 1 ml concentrated sulphuric acid was added from the 
sides of the test tube, appearance of red ring indicates the presence of triterpenoids. 
 
Test for Cyanins 
A. Aanthocyanin: 
To the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 min at 100
o
C. 
Formation of bluish green colour indicates the presence of anthocyanin. 
 
Test for Carbohydrates - Benedict‟s test 
To the test sample about 0.5 ml of Benedic‟s reagent is added. The mixture is heated 
on a boiling water bath for 2 minutes. A characteristic coloured precipitate indicates the 
presence of sugar. 
 
Proteins (Biuret Test) 
 To extracts 1% solution of copper sulphate was added followed by 5% solution of 
sodium hydroxide, formation of violet purple colour indicates the presence of proteins. 
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TLC Analysis 
 
Test sample was subjected to thin layer chromatography (TLC) as per conventional 
one dimensional ascending method using silica gel 60F254, 7X6 cm (Merck) were cut with 
ordinary household scissors. Plate markings were made with soft pencil. Micro pipette were 
used to spot the sample for TLC applied sample volume 10-micro liter by using pipette at 
distance of 1 cm at 5 tracks. In the twin trough chamber with different solvent system 
Toulene: Ethyl Acetate: Acetic Acid (1.5:1:0.5) after the run plates are dried and was 
observed using visible light Short-wave UV light 254nm and light long-wave UV light 365 
nm 
High Performance Thin Layer Chromatography Analysis 
 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to achieve 
precision, sensitive, significant separation both qualitatively and quantitatively. High 
performance thin layer chromatography (HPTLC) is a valuable quality assessment tool for 
the evaluation of botanical materials efficiently and cost effectively. HPTLC method offers 
high degree of selectivity, sensitivity and rapidity combined with single-step sample 
preparation. In addition it is a reliable method for the quantitation of nano grams level of 
samples. Thus this method can be conveniently adopted for routine quality control analysis. 
It provides chromatographic fingerprint of phytochemicals which is suitable for confirming 
the identity and purity of medicinal plant raw materials.  
 
Chromatogram Development 
 
It was carried out in CAMAG Twin Trough chambers. Sample elution was carried 
out according to the adsorption capability of the component to be analysed. After elution, 
plates were taken out of the chamber and dried. 
 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print was 
developed for the detection of phytoconstituents present in each extract and Rf values were 
tabulated.
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STERILITY TEST BY POUR PLATE METHOD 
 
Objective  
 
The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated / un sterile sample (formulation) when come in contact with the nutrition rich 
medium it promotes the growth of the organism and after stipulated period of incubation the 
growth of the organism was identified by characteristic pattern of colonies. The colonies are 
referred to as Colony Forming Units (CFUs).   
 
Methodology 
 
About 1ml of diluted test sample was inoculated in sterile petri dish to which about 15 
mL of molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting and 
swirling the dish. Agar was allowed to completely gel without disturbing it. (About 10 
minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. Grown colonies 
of organism was then counted and calculated for CFU.  
 
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
 
Result 
No growth / colonies were observed in any of the plates inoculates with the test sample. 
TEST RESULT SPECIFICATION 
AS PER 
AYUSH/WHO 
Total Bacterial Count Absent NMT 10
5
CFU/g As per AYUSH 
specification Total Fungal Count Absent NMT 10
3
CFU/g 
 
NMT- Not more than 
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Test for Specific Pathogen 
Methodology 
 
About 5ml of test sample was directly inoculated in to the specific pathogen medium 
(EMB, DCC, Mannitol, Cetrimide) by spread plate method. The plates were incubated at 
37
o
C for 24 - 72h for observation. Presence of specific pathogen identified by their 
characteristic color with respect to pattern of colony formation in each differential media. 
 
Abbreviation 
Organism Abbreviation 
E-coli EC 
Salmonella SA 
Staphylococcus Aureus ST 
Pseudomonas Aeruginosa PS 
 
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
 
Result 
No growth / colonies were observed in any of the plates inoculated with the test sample. 
Organism Specification Result Method 
E-coli Absent Absent  
As per AYUSH 
specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 
Pseudomonas Aeruginosa Absent Absent 
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SAFETY STUDIES:  
The experimental studies on animals were conducted at National Institute of Siddha 
Tambaram, Sanatorium. (IAEC NO:NIS/IAEC-III/10/29092016).  
 
ACUTE TOXICITY STUDY:  
Objective  
The objective of “Acute oral Toxicity Study of GM on Female Wistar rats was to 
measure the toxicological studies of the drug when treated as a single dose. Animal should 
be observed for 14 days after the drug administration.  
 
Test Guideline Followed:  
Acute toxicity was conducted as per OECD- 423 Guideline with slight modification.  
 
Materials and Methods:  
 
The study was conducted on Female Wistar rats. These animals were selected 
because of the recommended rodent species for oral studies as per followed guideline 
Female wistar rats, 8-12 weeks old, 140-160gm body weight were used for the study. The 
body weight range should be within ± 20% of the mean body weight at the time of 
Randomization and grouping. The rats were purchased from The Tamilnadu Veterinary and 
animal sciences university, Madhavaram milk colony, Chennai-600051. Rodent pelleted 
feed RO purified water ad libitum. Animals will be kept in polypropylene cages and 
numbered. 
 
Acclimatization:  
The animals were selected after veterinary examination by the veterinarian; selected 
rats were kept under acclimatization for a week.  
 
Randomization & grouping:  
After acclimatization, Rats were randomized as control and GM treated group. 
Control group received distilled water and the treatment group was administered with GM 
2gms/kg bd.wt.was a single dose p.o. 
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Identification:  
Animals were housed with appropriate identification by colouring the fur with picric 
acid solution prepared in water and with cage cards.  
 
Dose Preparation:  
GM was added in polysorbate solution with distilled water and completely dissolved 
for oral administration. The dose was prepared of a required concentration before dosing by 
dissolving, in distilled water. It was mixed well.  
 
Administration:  
A single dose of the solution (2000mg/kg) was consecutively administered by oral 
gavage using intubation cannula. Food was withheld for another 4 hrs after dosing and 
administration of drug. As per the guideline the starting dose level was taken as 2000mg/kg 
body weight. 
 
Observation period:  
After drug administration observations were started to be recorded at the ½ hr, 
1hour, 2hours, 4 hours on day one of dosing and twice daily after that for the next 13 
consecutive days. At the 14th day, sensory reactivity to stimuli of different types was 
conducted. Auditory stimuli responses were measured by clicker sound from approximately 
30 cm to the rats; visual stimuli response were measured with the help of shining pen light 
in the eye of rats and placing a blunt object near to the eye of rats. Response to 
proprioceptive stimuli was measured by placing anterior/dorsal surface of animals paw to 
the table edge. The responses of reactions for these three exercises were normal in animals 
belonging to both the controls as well as drug treatment dose groups. On day 15, the 
overnight fasted animals (water allowed ad libitum) were sacrificed and examine for gross 
pathological changes in the major internal organs.  
 
REPEATED DOSE 90DAYS ORAL TOXICITY STUDY:   
Objective:  
Repeated dose 90days oral toxicity study was conducted as per OECD-408 
Guideline. Animals should be observed for 90 days during the GM administration. Repeated 
dose 90days oral toxicity study give information on the health hazard likely to arise from 
frequent exposure over a relatively period of 90 days.  
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Test Guideline Followed  
OECD 408 Method – chronic toxicity study (Repeated Dose 90-Days Oral Toxicity 
Study in Rats).  
 
Good Laboratory Practices  
The study was conducted following the principles of good Laboratory Practice as set 
for the Principles of Good Laboratory Practice, OECD, 1998.  
 
Materials and methods  
Test System Detail  
Young adult Wister rats of 8-12 weeks old weighing 140-160 gms of both the sex 
was used for study. The body weight range should be within ± 20% of the mean body 
weight at the time of Randomization and grouping. Animals were housed in 4 groups 
(5/cage/sex) in polypropylene cages in a well-ventilated room under a temperature of 22 ± 
3°C and 30 - 70% relative humidity, with a 12-hr light/dark artificial light cycle. The rats 
were purchased from The Tamilnadu Veterinary and animal sciences university, 
Madhavaram milk colony, Chennai-600051. Rodent pelleted feed RO purified water ad 
libitum. Animals will be kept in polypropylene cages and numbered. 
 
Acclimatization  
The animals were selected after veterinary examination by the veterinarian. All the 
selected animals were kept under acclimatization for a week.  
 
Randomization & grouping:  
One day before the initiation of treatment (last day of acclimatization), the selected 
animals were randomly grouped into 4 different groups containing 10 male animals and 10 
female animals per group. 
 
Numbering and Identification:  
 
Animals were housed with appropriate identification by colouring the fur with picric 
acid solution prepared in water and with cage cards.  The group no., cage no., sex of the 
animal and animal no. were identified as indicated below using cage label and body 
marking on the animals: 
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Numbering and identification of animals in chronic toxicity study 
CAGE 
NO 
GROUP NO ANIMAL       MARKING SEX 
1. I CONTROL 1-10 
11-20 
Male 
Female 
2. II LOW DOSE 21-30 
31-40 
Male 
Female 
3. III MID DOSE 41-50 
51-60 
Male 
Female 
4. IV HIGH DOSE 61-70 
71-80 
Male 
Female 
 
Doses:  
The doses for the study were selected based on acute toxicity study. Following the 
period of fasting, the animals were weighed and then test drug was administered orally as 
single dose using a needle fitted on to a disposable syringe of approximate size at the 
following different doses.  
 
Numbering and identification of animals in chronic toxicity study 
CAGE 
NO 
GROUP NO ANIMAL       MARKING SEX 
1. I CONTROL 1-10 
11-20 
Male 
Female 
2. II LOW DOSE 21-30 
31-40 
Male 
Female 
3. III MID DOSE 41-50 
51-60 
Male 
Female 
4. IV HIGH DOSE 61-70 
71-80 
Male 
Female 
 
 The test item was administered for a period of 90 days. All animals in group I to IV 
were observed for 90 days.  
Observations:  
The observations included but were not restricted to changes in skin and the eyes 
and mucous membranes and in the respiratory, circulatory, central and autonomous nervous 
systems and behavior.  
 
71 
 
Clinical signs of toxicity:  
All the rats were observed at least two times daily with the purpose of recording any 
symptoms of ill- health or behavioral changes and clinical signs of toxicity daily for 90 days 
for animals in group I to IV.  
 
Food intake:  
A measured amount of feed was kept in the cages and then after 24 hrs the left out 
amount of feed was measured to calculate the amount of food consumed by the rats.  
 
Water intake:  
  
Water intake was observed by visual observation during the Study. In addition, the 
water consumption in each cage was observed daily for a period of 90 days.  
 
Bodyweight:  
 
The body weight of rats was recorded one week before the start of treatment, and 
during the course of the treatment on day one and weekly once. The mean weights for all 
groups and sexes were calculated from the individual weights.  
 
Pre-terminal deaths:  
All rats were observed twice daily for any pre terminal deaths.  
 
Blood Collection:  
 
Blood was collected through abdominal aorta from all the animals of four groups on 
90th day. The blood was collected in tubes containing as an anticoagulant (Heparin/EDTA). 
Animals were fasted overnight prior to the blood collection.  
 
Laboratory studies:  
During the 4th week of treatment, blood were withdrawn from the orbital sinus of 
animals from each group, under ketamine anesthesia .The blood samples are used to 
evaluate Hematological parameters like RBC, WBC, and platelets etc….. The collected 
blood samples also centrifuged 10000 rpm in 10 minutes to separate the serum. The 
separated serum used to evaluate biochemical parameters like SGOT, SGPT, ALP and 
BILIRUBIN etc……...  
72 
 
Hematology  
The following hematological parameters were analysed (Autoanalyser) Hb: 
Haemoglobin (g %), PCV: Packed Cell Volume, WBC : White Blood Corpuscles 
(x103/cmm) , RBC : Red Blood Corpuscles (x106/cmm) ,Blood Platelet count (x103/cmm)  
 
Differential WBC count:  
Clinical Biochemistry:  
The following clinical Bio parameters were analysed using Auto analyser. Total 
serum protein (g/dl) ,ALT/SGPT : Alanine amino transferase (U/L) ,AST/SGOT : Aspartate 
amino transferase (U/L) ,ALP : Alkaline serum phosphatase (U/L) ,CHL : Cholesterol 
(mg/dL) ,TGL : Triglyceride 
 
Sacrifice and macroscopic examination  
 
At the end of study period, the overnight fasted (water ad libitum) animals were 
anaesthetized with thiopentone sodium, blood samples were collected from retro-orbital 
sinus. After blood collection, the animals in group 1 to 4 were sacrificed on 90th day. 
 
Organ weights:  
 
After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Brain, Heart, Spleen Kidneys, sex organs, Liver and Lungs.  
 
Histopathology:  
 
The target organs from control and drug treated animals were preserved in 10 % 
buffered neutral formalin for histopathological examination. Control and highest dose 
animals will be initially subjected to histopathological investigation. If any abnormality 
were found in the high dose group and then the low and mid group will be examined. All 
deviations from normal histology were recorded and compared with corresponding controls.  
 
Statistical analysis:  
 
Values are expressed as mean ± SD. Statistical significance (p) calculated by one 
way ANOVA followed by dunnett‟ s. P< 0.05 considered as significant by comparing 
treated group with control group. 
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CLINICAL STUDY:  
Clinical trial Approval & Registration:  
The Clinical trial was approved by the Institutional Ethics Committee (IEC) of 
National Institute of Siddha, Chennai 47 (NIS/IEC/2016/11-15/14.10.16) and further 
registered in Clinical Trial Registry of India (CTRI/2018/04/013023).  
 
Study Centre:  
 
Clinical study was conducted at AyothidossPandither Siddha Hospital, National 
Institute of Siddha (NIS), Tambaram Sanatorium, Chennai - 47. Necessary permission was 
obtained from the Administrative head to conduct the study.  
 
SUBJECT SELECTION: 
 
         Patients reporting with symptoms of inclusion criteria would be subjected to screening 
test and documentation. 
 
INCLUSION CRITERIA: 
 Age : 30-65 years 
 Sex : Both male and female 
 Patient includes diabetic ulcer. 
 With or without Pain, Itching, Edema, Fibrinous exudates in the lesions 
 Hyper pigmentation 
 Inflammation & Induration                                                                                                         
 Willing to give specimen of blood for the investigation.  
 Willing to take photograph. 
 Willing to participate in trial and signing consent by fulfilling the condition of   
Proforma. 
 
EXCLUSION CRITERIA: 
 Extensive and localized Gangrene require amputation 
 Osteo Myelitis  
 Deep ulceration with bone, joint involvement  
 Varicose ulcer 
 Hansen‟s disease 
 Tuberculous ulcer  
 Any other systemic illness. 
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WITHDRAWAL CRITERIA: 
 
 Intolerance to the drug and development of any serious adverse effect during drug 
trial. 
 Poor patient compliance & defaulters 
 Patient unwilling to continue the course of clinical study. 
 Occurrence of any other systemic illness. 
 
TESTS AND ASSESMENTS: 
            1. Clinical assessment  
2. Siddha system assessment 
3. Routine investigations 
 
CLINICAL ASSESMENT: 
 Presence of ulcers 
 Delay wound healing process 
 With or without Pain, Itching, Edema, Fibrinous exudates in the lesions 
 Hyper pigmentation  
 Inflammation   and Induration                                                                                               
 
INVESTIGATIONS BASED ON SIDDHA SYSTEM: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram 
 Neerkkuri:    
 Neikkuri: 
75 
 
 
1. INVESTIGATION: 
BLOOD 
 Hb 
 Total WBC Count 
 DC 
 Polymorphs 
 Lymphocytes  
 Eosinophils 
 Monocytes  
 Basophils  
 Total RBC count  
 ESR    ½ Hr:        1 Hr: 
 Blood sugar  
Fasting:    PP: 
 Serum cholesterol 
 
URINE 
 Albumin 
 Sugar(F)                          (PP) 
 Deposits 
 
RENAL FUNCTION TESTS 
             Blood Urea 
             Serum Creatinine 
             Uric acid 
 
LIVER FUNCTION TESTS 
              Serum total bilirubin 
              Direct bilirubin 
              Indirect bilirubin 
              Serum Alkaline phosphatases 
              SGOT 
              SGPT 
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PRIMARY OUTCOME: 
 
 The Outcome of  the study was assessed  by bates-jensen wound assessment tool etc. 
 
BASED ON WOUND STATUS CONTINUUM 
Wound Regeneration -13  
Wound degenration – 60 
 
GOOD   :  Complete healing of ulcer  
MODERATE  :  Partial healing of ulcer  
MILD   :  Slight reduction of ulcer  
POOR   :  No reduction of ulcer  
 
SECONDARY OUTCOME: 
 To Assess Safety of the trial drug 
 
DATA COLLECTION: 
Required information was collected from each patient by using the following forms 
 
FORMS:  
FORM I            Screening and selection Proforma 
FORM II           Clinical assessment Proforma 
FORM III          Laboratory investigation Proforma 
FORM IV         Drug compliance form  
FORM V          Patient information sheet 
FORM VI         Consent form 
FORM VII       Withdrawal form/Pharmacovigilance 
FORM VIII      Dietary Advice form 
 
STUDY ENROLLMENT: 
 
 Patients reporting at the OPD with clinical feature of chronic ulcer, oedema, 
Fibrinous exudates, present in the ulcer are chosen for enrollment based on the 
inclusion and exclusion criteria. 
77 
 
 The enrolled patients were informed about the study, trial drug, possible outcomes 
and the objectives of the study in the language and terms understandable to them and 
getting consent in the informed Consent form (Form VI). 
 
 Complete clinical history, complaints and duration, examination findings- all are 
recorded in the prescribed Performa‟s. 
 
Screening Form- I would be filled up, Form –II and Form –III would be used for recording 
the patients, history, clinical examination of symptoms and signs and laboratory 
investigations respectively. If there is any abnormal laboratory reports obtained then 
excluded from this study. Patients would be advised to take the trial drug and appropriate 
dietary advice (Form VIII)   would be given according to the patients, perfect 
understanding. 
 
CONDUCT OF THE STUDY: 
The day before the treatment Purgation were given with Agasthiyar Kuzhambu -
200mg in the early morning in empty stomach with Sangankuppi chaaru for balancing the 
deranged mukkutram. Then the trial drugs “GANDHI MATHIRAI” (Internal) and 
“SAGALA RANANGALUKUM KALIMBU” (External) were given for 48 days.   
 
  OPD patients are requested to visit the hospital every day. In each and every visit 
clinical assessment and prognosis were recorded every seven days once. For IPD patients 
the clinical assessment and prognosis were recorded daily.  
 
            Laboratory investigations were done before and after the trial. For IPD patients, who 
are not in a position to stay in the hospital for 48 days, are advised to attend the OPD for 
further follow-up.At the end of the trial, the patients are advised to visit the OPD for further 
2 months for follow-up for any recurrence. Defaulters will not be allowed to continue and 
were withdrawn from the study with fresh case being inducted. 
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PHYSICO-CHEMICAL ANALYSIS RESULTS 
 
S.NO PARAMETERS RESULTS 
1. Description  Solid state 
      Colour Black  
      Odour Mild characteristic odour 
2. Weight variations Average weight of 0.0346 which is under the 
category of less than 80 mg 
3. Disintergration time 5-8 min 
 
TEST FOR ACID FREE RADICLES: 
S.NO                     PROCEDURE RESULTS 
1. Test for sulphate + 
2. Test for chloride - 
3. Test for phosphate + 
4. Test for carbonate + 
5. Test for nitrate  - 
6. Test for sulphide - 
7. Test for fluride and oxalate  - 
8. Test for borate - 
 
Inference Bio-chemical analysis for acid radicals reveals that Gandhi mathirai contains 
sulphate, phosphate, and carbonate. 
 
TEST FOR BASIC RADICLES: 
S.NO                     PROCEDURE RESULTS 
1. Test for lead - 
2. Test for copper - 
3. Test for alumium + 
4. Test for iron + 
5. Test for zinc - 
6. Test for calcium - 
7. Test for magnesium - 
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8. Test for ammonium - 
9. Test for pottasium - 
10. Test for sodium - 
11. Test for mercury - 
12. Test for arsenic - 
 
Inference Bio-chemical analysis for basic radicals reveals that Gandhi mathirai contains 
aluminum and Iron. 
MISCELLANEOUS: 
 
S.NO PROCEDURE RESULTS 
1. Test for starch - 
2. Test for reducing sugar - 
3. Test for alkaloids + 
4. Test for tannic acid + 
5. Test for unsaturatedcompound - 
6. Test for the type of compound 
Oxy quinole epinephrine and pyro 
catechol 
 
+ 
 
Inference Bio-chemical analysis for miscellaneous reveals that Gandhi mathirai contains 
alkaloids, tannic acid  and  oxy quinole epinephrine. 
 
PHYTO CHEMICAL ANALYSIS: 
S.NO PROCEDURE RESULTS 
1. Alkaloid  - 
2. Flavonoids  + 
3. Glycosides  + 
4. Steroids  - 
5. Triterpenoids  - 
6. Coumarin  + 
7. Phenols  + 
8. Tannin  + 
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9. Protein  - 
10. Saponins  + 
11. Sugar  - 
12. Anthocyanin  - 
13. Betacyanin  - 
 
RESULTS 
Test for Alkaloids  Test for Flavonoids  Test for Glycosides 
 
        
 
Test for Steroids   Test for Triterpenoids Test for Coumarins 
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Test for Phenols    Test for Tanins  Test for Protein 
 
         
 
Test for Saponins    Test for Carbohydrates       Test for Anthocyanins/  
        Beta cyanins 
 
  
  
  
   
 
 
 
 
 
 
Inference: phyotchemical analysis reveals that Gandhi mathirai contains flavonoids, 
tannin, glycosides,coumarin, phenols,saponins. 
 
HEAVY METAL ANALYSIS 
 
HEAVY 
METAL 
SPECIFICATION AS PER 
AYUSH/WHO/FDA 
OBSERVED 
RESULT 
Lead 10ppm 0.93ppm 
Cadmium 0.3ppm 9.4 
Arsenic 3.0ppm 1.344 
Mercury 1ppm BDL 
 
Inference: The heavy metals such as cadmium, arsenic and mercury are not detected and 
the presence of lead is within the permissible limit.  
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TEST FOR AFLATOXINS AND PESTICIDE RESIDUES 
 
S.NO TEST OBSERVED RESULT 
1. Aflatoxin B1 ND 
2. Aflatoxin B2 ND 
 
3. Aflatoxin G1 ND 
 
4. Aflatoxin G2 ND 
5. Organophosphorus ND 
6. Organochloride ND 
7. Synthetic pyrethroids ND 
 
 
TEST FOR BACTERIAL AND FUNGAL COUNT 
 
TEST SPECIFICATION AS PER 
AYUSH/WHO/FDA 
OBSERVED RESULT 
Total bacterial count NMT 105 CFU/g 34,000CFU/g 
 
Total fungal count NMT 103 CFU/g < 10 CFU/g 
 
E.coli Ab/ g Ab/ g 
 
Salmonella Ab / g Ab/ g 
 
Pseudomonas 
aeruginosa 
Ab/ g Ab/ g 
 
Staphyloccusaureus Ab / g Ab/ g 
 
 
Inference: The bacterial and fungal loads are within the prescribed limits. The above results 
suggest that the prepared drug Gandhi mathirai is standard quality. 
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THIN LAYER CHROMATOGRAPHY CONDITIONS  
 
S.NO MOBILE PHASE RF VALUE NO OF 
COMPOUNDS 
DETECTION 
1. Toluene: Ethyl 
Acetate: 
Acetic(1:5:1:0:5)Acid: 
Acetone() 
0.06 and 0.93 6 254nm 
 
 
TLC PROFILE OF GM (PHOTO DOCUMENTATION) 
 
TLC Analysis at 254 nm    TLC Analysis at 366 nm 
 
 
 
 
 
 
 
 
 
 
 
 
TLC plate visulization at visible range      TLC after derivatization with 10% sulfuric acid  
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Track at All Wavelength 
 
 
 
HPTLC finger printing of Sample GM 
 
Peak Table 
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RESULTS 
 
HPTLC finger printing analysis of the sample GM reveals the presence of three 
prominent peaks corresponds to presence of six versatile phytocomponents present with in 
it. Rf value of the peaks ranges from 0.06 to 0.93.  Further the peak 2 occupies the major 
percentage of area of 56.11 % which denotes the abundant existence of such compound. 
Followed by this peak 1 and 2 occupies the percentage area of 16.15 and 13.36%. 
 
PESTICIDE RESIDUES 
Test Result Analysis of the Sample GM 
 
Pesticide Residue  Sample GM AYUSH Limit (mg/kg) 
I. Organo Chlorine Pesticides 
Alpha BHC  BQL 0.1mg/kg 
Beta BHC BQL 0.1mg/kg 
Gamma BHC BQL 0.1mg/kg 
Delta BHC  BQL 0.1mg/kg 
DDT BQL 1mg/kg 
Endosulphan BQL 3mg/kg 
II.Organo Phosphorus Pesticides    
Malathion  BQL 1mg/kg 
Chlorpyriphos  BQL 0.2 mg/kg 
Dichlorovos  BQL 1mg/kg 
III.Pyrethroid Cypermethrin  BQL 1mg/k 
 
BQL- Below quantification Limit  
 
Result: 
The results showed that there were no traces of pesticides residues such as Organo 
chlorine, Organo phosphorus and pyrethroids in the sample GM. It further shows the above 
mentioned residues were not been detected in the sample GM provided for analysis. 
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TOXICITY STUDY 
Acutetoxicity 
 
Gandhi mathirai was administered single time at the dose of 2gms/kg to rats and 
observed for consecutive 14 days after administration. According to the OECD guideline 
423 when there is information in support of non-toxicity or low and immortality nature of 
the test substance, then the limit test at the dose level 2 gms/kg body weights (highest 
starting dose level) was conducted. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No mortality was 
observed during the total period of the study. Data obtained in this study indicated no 
significance physical and behavioural signs of any toxicity due to administration of Gandhi 
mathirai at the dose of 2gms/kg to rats. At the 14th day, all animals were observed for 
functional and behavioural examination. In functional and behavioural examination, home 
cage activity, hand held activity were observed. Home cage activities like Body position, 
Respiration, involuntary movement, (Clonic and Tonic), Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities (Reactivity and Handling), Palpebral closure, Lacrimation, 
Salivation, Piloercetion, Papillary reflex, abdominal tone, Limb tone were observed. 
Functional and behavioural examination was normal in all groups. Food consumption of all 
treated animals was found normal as compared to control group. The results of functional 
and behavioural examination were elicited in table below. 
 
CLINICAL OBSERVATION OF CONTROL AND GANDHI MATHIRAI TREATED 
EXPERIMENTALANIMALS IN ACUTE TOXICITY STUDY 
 
OBSERVATION SIGNS OBSERVATION SIGNS 
Lethality    X Stereotypies(chewing)    X 
Convulsion    X Stereotypies 
(Head movements) 
   X 
Tremor    X Head twitches    X 
 Straub tail    X Scratching    X 
Sedation 
 
#1    X Respiration    X 
#2    X Aggressiveness    X 
#3    X Fear    X 
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Excitation #1    X Reactivity to touch     X 
#2    X Muscle tone    X 
 #3    X Loss of rightingReflex    X 
Abnormal gait(rolling)    X Ptosis     X 
Abnormal gait(tip toe)    X Exophthalmos    X 
Jumps     X Loss of grasping    X 
Motor coordination    X Akinesia     X 
Loss of balance    X Catalepsy    X 
Fore paw treading    X Loss of traction    X 
Writhes    X Loss of corneal reflex    X 
Piloerection    X Analgesia    X 
Salivation    X Defecation    X 
Lacrimation    X Others    X 
Others X X – no sign / √ - Present; Values are expressed as mean ± SD (n=3) 
 
Body weight at weekly interval was measured to find out the effect of Gandhi 
mathirai on the growth rate. No significant body weight changes were observed between 
control and treatment group. There were no treatment related mortality in both control and 
treatment groups throughout the experimental period No pathological (gross) changes were 
observed in the experimental animals  
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EFFECT OF GANDHI MATHIRAI ON BODY WEIGHT OF WISTAR RATS IN 
ACUTE TOXICITYSTUDY 
 
TREATMENT Body weight (mean±SD) 
Day 1 Day 7 Day 14 
Control 145±0.58 156.5±0.35 166.5±0.58 
GM 
(2000mg/kg) 154.3±0.81 165.5±0.65 178±0.32 
 
Values are expressed as mean ±SD. Statistical significance (p) calculated by one 
way ANOVA followed by dunnett‟ s. P< 0.05 considered as significant by comparing 
treated group with control group using Graph Pad 3. 
 
 
Effect of GM on Body weight in WA Rats 
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GROSS PATHOLOGY OBSERVATIONS OF CONTROL AND GANDHI 
MATHIRAI TREATED EXPERIMENTAL ANIMALS 
 
ORGANS OBSERVATION 
Brain  No abnormal lesion observed 
Eyes No abnormal lesion observed 
Lymph node No abnormal lesion observed 
Trachea No abnormal lesion observed 
Oesophagus No abnormal lesion observed 
Lungs No abnormal lesion observed 
Heart No abnormal lesion observed 
Brain No abnormal lesion observed 
Liver  No abnormal lesion observed 
Stomach No abnormal lesion observed 
Duodenum No abnormal lesion observed 
Small and large intestine No abnormal lesion observed 
Kidney No abnormal lesion observed 
Spleen No abnormal lesion observed 
Sex organs No abnormal lesion observed 
Pancreas No abnormal lesion observed 
 
REPEATED DOSE 90 DAYS ORAL TOXICITY STUDY:  
Clinical Signs : 
 
No abnormal home cage activities, behavioral responses or neurological symptoms 
were observed before and after the exposure of GM. All animals in this study were free of 
toxic clinical signs throughout the dosing period of 90days  
 
Mortality:  
Since examination of clinical signs plays main role in toxicological testing, mortality 
and morbidity were recorded two times a day throughout the study. All animals in control 
and in all the treated dose groups survived during the dosing period of 90 days  
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Body weight:  
Results of body weight determination of animals from control and different dose 
groups exhibited comparable body weight gain (throughout the dosing period of 90 days  
 
Food and water consumption:  
 
Feed and water consumption of GM treated groups were found to be in significant in 
both the sexes when compared to control. The faecal/urinary excretion patterns were also 
found to be normal in GM administered rats in comparison to the vehicle treated rats.  
 
CLINICAL OBSERVATION OF CONTROL AND GM TREATED 
EXPERIMENTAL ANIMALS IN- REPEATED DOSE 90DAYS ORAL TOXICITY 
STUDY 
OBSERVATION SIGNS OBSERVATION SIGNS 
Lethality    X Stereotypies(chewing)    X 
Convulsion    X Stereotypies 
(Head movements) 
   X 
Tremor    X Head twitches    X 
 Straub tail    X Scratching    X 
Sedation 
 
#1    X Respiration    X 
#2    X Aggressiveness    X 
#3    X Fear    X 
Excitation #1    X Reactivity to touch     X 
#2    X Muscle tone    X 
 #3    X Loss of rightingReflex    X 
Abnormal gait(rolling)    X Ptosis     X 
Abnormal gait(tip toe)    X Exophthalmos    X 
Jumps     X Loss of grasping    X 
Motor coordination    X Akinesia     X 
Loss of balance    X Catalepsy    X 
Fore paw treading    X Loss of traction    X 
Writhes    X Loss of corneal reflex    X 
Piloerection    X Analgesia    X 
Salivation    X Defecation    X 
Lacrimation    X Others    X 
 
Others X X – no sign / √ - Present; Values are expressed as mean ± SD (n=3) 
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EFFECT OF GANDHI MATHIRAI ON BODY WEIGHT OF EXPERIMENTAL 
WISTAR RATS IN 90 DAYS REPEATED ORAL TOXICITY STUDY 
 
 
Values are expressed as mean ± SD. Statistical significance (p) calculated by one way 
ANOVA followed by dunnett‟s. P< 0.05 considered as significant by comparing treated 
group with control group using Graph Pad Prism 3.0. 
 
 
 
Effect of GM on Body weight in WA Rats 
 
0
50
100
150
200
250
CHRONIC BODY WEIGHT
CONTROL
11.7 mg/kg
58.5 mg/kg
117 mg/kg
Treat-
ment 
1st 
Day 
14th day 28th day 56th 
day 
70th 
Day 
84th day 90th 
Control 145.90± 0.6 
 
155±2.0 160.4± 036 
 
163.20± 0.85 
 
170.40± 0.98 
 
179.3± 0.96 
 
188.3± 0.98 
 
11.7 
mg/dl 
140±0.9 150.7±0.45 162.3±0.21 
 
169.21±0.63 
 
174.70± 0.74 
 
180.30± 0.14 
 
186.4± 0.54 
 
58.5 
mg/dl 
142±0.34 152±0.45 
 
163.1± 0.35 
 
170.31± 0.65 
 
176.3±0.69 
 
185.4± 0.36 
 
190± 0.87 
 
117 
mg/dl 
145±0.23 155±0.63 
 
166± 0.69 
 
172.4±86.2 
 
179.50±0.86 
 
188.6± 0.87  
 
200.10± 0.36 
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The haemopoietic system serves as vital goal for toxic chemicals and is a susceptible 
index for pathological conditions both in humans and animals. The results of hematological 
investigations conducted on day 90 does not revealed any significant changes in the values 
of various parameters observed when compared with those of respective controls . 
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EFFECT OF GANDHI MATHIRAI ON HEMATOLOGICAL PARAMETERS OF 
EXPERIMENTAL WISTAR RATS IN REPEATED DOSE 90DAYS ORAL 
TOXICITY STUDY 
 
TREATMENT RBC(106/uL) 
WBC (103/uL 
 
PLATELET 
103/uL 
HB mg/dl 
Control 5.76  ± 0.512 9.02  ± 2.14 759 ± 75.7 12.35 ± 1.82 
11.7mg/dl 6.885  ±0.81 9.5  ± 2.28 730.6  ± 1.27 13.0 ± 1.37 
58.5mg/dl 6.81 ± 0.57 9.75 ± 2.21 629.4  ± 90.0 12.54± 1.59 
117mg/dl 6.5  ± 1.010 8.27 ± 1.52 747.7 ± 23.2 12.98  ±1.26 
 
RBC: red blood corpuscles; Hb: hemoglobin; MCH: mean corpuscular hemoglobin; WBC: 
white blood cells PCV: packed cell volume. Values are expressed as mean ± SD. 
 Statistical significance (p) calculated by one way ANOVA followed by dunnett‟ s. P< 0.05 
considered as significant by comparing treated group with control group using Graph Pad 
Prism 3.0. 
BIOCHEMICAL INVESTIGATIONS  
Clinical biochemistry and hematological data holds major role in determining the toxicity 
induced by drugs. Transaminases (SGPT and SGOT) are good indicator of liver function 
and biomarkers to calculate the possible toxicity of drugs. Any elevation pertaining to these 
enzymes specifies their out flow into the blood stream due to injure in liver parenchymal 
cells. Results of Biochemical investigations conducted on days 90 does not revealed 
significant changes in the values of hepatic serum enzymes studied when compared with 
those of respective control. 
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EFFECT OF GANDHI MATHIRAI ON BIOCHEMICAL PARAMETERS OF 
EXPERIMENTAL WISTAR RATS IN REPEATED DOSE 90DAYS ORAL 
TOXICITY STUDY 
 
 
Treatment 
SGPT 
U/I 
 
SGOT 
U/I 
 
Total 
Bilirubin 
mg/dl 
 
Total 
Cholestrol 
mg/dl 
 
TGL 
mg/dl 
 
Creatinine 
mg/dl 
 
Control 88.5 ± 0.74 88.2 ±11.1 0.33 ±0.166 108.7 ±13.4 48.6 ± 
4.86 
0.68 ±0.218 
11.7mg/dl 32.82 ± 8.88 90.3 ±20.5 0.515 ±0.36 118.2 ± 18.2 40.2 ±6.5 0.705 ±0.26 
58.5mg/dl 32 ± 9.13 92.05 ±22.3 0.445 ±0.25 128.9 ±10 39.2 ±6.9 0.7 ±0.16 
117mg/dl 32.35 ± 9.13 97 ±15.8 0.43 ±1.082 108.2 ±12.2 35.8 ±7.5 0.63 ±0.29 
 
TGL: triglycerides, SGOT: Serum Glutamic oxaloacetic Transaminase, SGPT: serum 
glutamic pyruvic transaminase, ALP: Alkaline phosphatase. Values are expressed as mean 
± SD. Statistical significance (p) calculated by one way ANOVA followed by dunnett‟s. P< 
0.05 considered as significant by comparing treated group with control group using Graph 
Pad Prism 3.0. 
 
HISTOPATHOLOGY:  
 
Histopathological studies give supportive evidence for biochemical and 
haematological observations. The histopathological examination carried out in the control 
and high dose animals treated with GM. In histopathological examination, revealed normal 
architecture in comparison with control and all treated group animals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORGANS OBSERVATION 
Brain No abnormal lesion observed 
Heart No abnormal lesion observed 
Liver No abnormal lesion observed 
Spleen No abnormal lesion observed 
Kidney No abnormal lesion observed 
Lung No abnormal lesion is observed 
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EFFECT OF GM ON HISTOPATHOLOGICAL CHANGES IN RAT ORGANS 
REPEATED DOSE 90DAYS ORAL TOXICITY STUDY: 
 
Control Male 
Histopathology of Heart 
 
       Low Power Magnification 10X                         High Power Magnification 40X 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Lung  
 
   Low Power Magnification 10X        High Power Magnification 40X 
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Histopathology of Liver  
 
    Low Power Magnification 10X         High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Kidney 
 
     Low Power Magnification 10X                           High Power Magnification 40X 
   
 
     
98 
 
Histopathology of Spleen 
 
Low Power Magnification 10X                 High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Testes 
 
 
     Low Power Magnification 10X        High Power Magnification 40X 
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Results 
 
Heart No evidence of atherosclerosis and thrombosis 
No evidence of necrotic myocardium 
Lung Alveolar sac and septa appears normal with signs of degeneration 
Liver Appearance of terminal hepatic venules (central veins) to the portal 
tracts was normal 
No signs of nodular degeneration and cirrhosis 
Kidney Appearance of glomerular basement membrane was normal 
Lumen of vessels and bowman‟s space appears normal 
Spleen Presence of marginal at the interface of the red pulp with the PALS and 
follicles was observed 
Marginal sinus (MS) of the rat and its sinus lining cells appears normal 
Testes Presence of mature somatic cells project the perfect histomorphology of 
testicular cells were observed. Primary spermatocytes with large 
centered nucleus and dense chromatin were observed 
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Control Female 
Histopathology of Heart 
 
 
     Low Power Magnification 10X                      High Power Magnification 40X 
 
 
Histopathology of Lung  
 
 
       Low Power Magnification 10X                High Power Magnification 40X 
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Histopathology of Stomach  
 
Low Power Magnification 10X                High Power Magnification 40X 
 
 
 
 
Histopathology of Liver 
 
         Low Power Magnification 10X          High Power Magnification 40X 
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Histopathology of Kidney 
 
 
        Low Power Magnification 10X                        High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Spleen  
 
        Low Power Magnification 10X                            High Power Magnification 40X 
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Histopathology of Uterus  
 
        Low Power Magnification 10X                       High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Ovary  
 
 
Low Power Magnification 10X                           High Power Magnification 40X 
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Results 
Heart Appearance of fibrils and cross striations are equidistant 
 
Lung Perivascular region appears normal, Alveolar septa and wall appeared widen and 
normal 
Stomach Regular histology of Inner circular muscle (ICM), gastric pit (GP), and muscularis 
mucosae (MM) were observed 
 
Liver Centrilobular zone appears normal with stable network of hepatocytes 
The walls of the lumen appears normal with no evidence of ischemic changes. 
 
Spleen Appearance of splenic sinuses, Splenic cord and endothelial orientation was normal 
Uterus Endometrial stroma; G, gland; M, myometrium; P, perimetrium; L, lumen exhibits 
normal histological aspect of endometrium and myometrium. 
 
Ovary Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality 
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HDMB- GM 
Histopathology of Brain  
 
Low Power Magnification 10X                               High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Heart  
Low Power Magnification 10XHigh Power Magnification 40X 
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Histopathology of Lung  
 
      Low Power Magnification 10X    High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Stomach  
 
       Low Power Magnification 10X                          High Power Magnification 40X 
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Histopathology of Liver 
  
         Low Power Magnification 10X        High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Kidney 
 
Low Power Magnification 10X  High Power Magnification 40X 
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Histopathology of Spleen  
 
Low Power Magnification 10X   High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Testes 
Low Power Magnification 10X   High Power Magnification 40X 
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Results 
 
 
Brain In cerebellum the molecular, purkinje and granular layers, appeared clear 
and distinct without any changes. 
Heart Fibres appears normal elongated and rod shaped 
Lung Respiratory and terminal bronchioles appears normal 
Stomach Normal gastric mucosa containing intact gastric gland cells, parietal cells 
which are spherical cell with deeply stained dark nucleus 
Liver The centrilobular hepatocytes appears normal  with stained prominent 
cytoplasm 
Kidney Appearance of proximal and distal convolutes tubules was normal 
Spleen Appearance of splenic red pulp was normal 
Testes Section of testis of showing normal interstitial connective tissue and normal; 
proliferating highly divided germ cells with elongated sertoli cells 
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HDFH- GM 
Histopathology of Heart  
Low Power Magnification 10X  High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Lung  
 
 
       Low Power Magnification 10X       High Power Magnification 40X 
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Histopathology of Stomach  
 
      Low Power Magnification 10X            High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Liver  
Low Power Magnification 10X  High Power Magnification 40X 
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Histopathology of Kidney 
 
           Low Power Magnification 10X          High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathology of Spleen  
 
Low Power Magnification 10X  High Power Magnification 40X 
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Histopathology of Uterus 
 
Low Power Magnification 10X       High Power Magnification 40X 
 
 
 
Histopathology of Ovary  
 
 Low Power Magnification 10X      High Power Magnification 40X 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
Results 
 
 
Heart Nucleus appears prominent with regular arrangement of fibres. No evidence 
of pyknotic nucleus 
Lung Inter alveolar septum and alveolar capillary appears normal 
Stomach Mucosal wall appears normal with regular arrangement of connective tissue 
Liver Section of liver showing normal, homogenous, intact hepatic parenchyma; 
hepatic lobules, with normal central vein. 
Kidney Normal renal structure with rounded renal corpuscles formed of the 
Glomerulus (G) and the Bowman‟s capsule (B) surrounded with Proximal 
Convoluted Tubule (PCT), Distal Convoluted Tubule (DCT) and Collecting 
Duct (CD). 
Spleen No signs of immunological activities 
Marginal sinus (MS) of the spleen and its sinus lining cells appears normal 
Uterus Appearance of endometrium, myometrium and uterine glands was normal 
Ovary Follicular cells, cytoplasm and nucleus appears normal 
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CLINICAL STUDY 
 
The observation and results were studied and tabulated under the following heading.  
 
1. Sex distribution  
2. Age distribution  
3. Occupational status  
4. Diet habits  
5. Thinai reference  
6. Kaalam distribution  
7. Yakkai Ilakkanam (Physical Constitution)  
8. Duration of illness  
9. Clinical features  
10. Distributions of three thodams  
11. UdarKattukkal reference  
12. En Vagaithervugal  
13. Neerkkuri reference  
14. Neikkuri reference  
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SEX DISTRIBUTION 
 
S.NO SEX DISTRIBUTION NO OF CASES PERCENTAGE 
1. Male 21 Male 70% 
2. Female 9 Female 30% 
 
 
 
 
 
 
 
Observation: Among the 30 patients selected for this study, 70% were males and 30% 
females. 
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AGE GROUP: 
  
 
 
S.NO AGE NO OF CASES RESULTS 
1. 35-45 years 6 20.1% 
2. 46-55 years 11 36.6% 
3. 56-65 years 13 43.3% 
    
 
 
          
 
 
 
 
Observation: The patients were selected from all age groups as given above and the 
maximum numbers of patients were in the age between 56 and 65yrs. 
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OCCUPATIONAL STATUS: 
 
SL. 
NO 
NATURE OF WORK NO. OF CASES PERCENTAGE 
1. Farmer 6 20% 
2. Security 1 3.3% 
3. Fisher man 1 3.3% 
4. Shop keeper 2 6.6% 
5. Administration Work 1 3.3% 
6. Teacher 1 3.3% 
7. Conductor 1 3.3% 
8. Businessman 6 20% 
9. Others 11 36.6% 
 
 
 
 
Observation:  
Out of 30 patients reported, 20% of patients were work in agriculture, 3.3%of 
patients were work in security, fishermen, teacher, conductor, administrative work,6.6 % of 
patients were work in shopkeeper.36.6% of patients were work in other field. The results 
did not declare DU as an occupational related disease.  
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DIET HABITS  
 
S.NO DIETRY HABITS NO OF CASES RESULTS 
1. Vegetarian 6 20% 
2. Non vegetarian 24 80% 
 
 
 
 
 
 
Observation: 80% of the patients were non-vegetarians. 
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THINAI 
S.NO THINAI NO OF CASES RESULTS 
1. Kurinji            -             - 
2. Mullai            -             - 
3. Marutham           18           60% 
4. Neithal           12           40 
5. Paalai            -            - 
 
 
 
 
 
 
Observation: 60% of the patients were from Neithal (Coastal Area) and (40%) from 
Marutham (Fertile Land). 
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KAALAM DISTRIBUTION  
 
S.NO         KAALAM   NO OF CASES RESULTS 
1. Kaar kaalam                - - 
2. Koothir kaalam                -  - 
3. Ilavenir kaalam              14 46.6 
4. Muthuvenir               9 30.2 
5. Mun pani               2 6.6 
6. Pin pani               5 16.6 
   
 
 
 
Observation: 75% of the patients admitted in Ilavenilkaalam and the remaining 
25% patients were admitted in Pinpanikaalam. 
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YAAKAI ILAKKANAM(PHYSICAL CONSTITUENTS):  
 
S.NO YAAKAI ILAKANAM NO OF CASES RESULTS 
1. Vatha udal -  
2. Pitha udal -  
3. Kaba udal -  
4. Thontha udal 30 100% 
 
 
  
 
Observation: All the patients (100%) had Thontha udal. 
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DURATION OF ILLNESS: 
 
S.NO DURATION OF ILLNESS NO OF CASES RESULTS 
1. 15 days – 1 year 25 83.3% 
2. 2 – 5 years 4 13.3% 
3. 6-10 years - - 
4. 11-20 years 1 3.3% 
 
 
 
Observation: 83.3% of the patients were suffering sudden onset within the years. 
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CLINICAL FEATURES 
 
S.NO CLINICAL FEATURES NO OF CASES RESULTS 
1. Ulcer with or without pain 30 100% 
2. Oozing 30 100% 
3. Foul smell 25 83.3% 
4. Numbness of foot 18 60% 
5. Burning sensation 10 33.3% 
6. Ulcer involve with 
muscle,tendon,bone. 
- - 
7. Osteomyelitis - - 
 
 
 
Observation:  
Among the 30 patients, 100% of cases with the symptoms of ulcer with or without 
pain and oozing,83.3% of cases with the symptoms of foul smell,16% of patients were 
numbness foot,33.3% of patients with the symptoms of burning foot.  
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DISTRIBUTION OF MUKKUTRAM:  
VATHAM: 
S.NO VATHAM NO OF CASES RESULTS 
1. Pranan - - 
2. Abanan 5 16.6% 
3. Uthanan - - 
4. Viyanan 30 100% 
5. Samanan 30 100% 
6. Naagan - - 
7. Koorman - - 
8. Kirugaran - - 
9. Thevathathan - - 
10. Thananjeyan - - 
 
 
 
Observation: Samaanan and Viyaanan were affected in all the 30 patients. Abanan were 
affected in 5 patients respectively. 
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PITHAM: 
S.No Pitham No Of Cases Results 
1. Anarpitham - - 
2. Ranjaga Pitham 5 16.6% 
3. Pirasagam 30 100% 
4. Aalosagam - - 
5. Sathagam 30 100% 
 
   
 
 
Observation: Saathaga pitham and Pirasaga pitham were affected in all the cases.Ranjaga 
pitham affected 5 patients respectively. 
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KABAM: 
S.NO KABAM NO OF CASES RESULTS 
1. Avalambagam - - 
2. Klethagam 1 3.3% 
3. Pothagam - - 
4. Tharpagam - - 
5. santhigam - - 
 
 
 
 
 
Observation: In Kabam klethagam was affected in 1 patient. 
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UDAR KATTUGAL:  
S.NO UDAR KATTUGAL NO OF CASES RESULTS 
1. Saram 30 100% 
2. Seneer 30 100% 
3. Oon 30 100% 
4. Kozhuppu 30 100% 
5. Enbu - - 
6. Moolai - - 
7. Sukkilam/suronitham - - 
 
 
 
Observation: Among 30 patients, Saaram ,Seneer, oon, kozhuppu were affected in all the 
cases. 
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ENVAGAI THERVUGAL:  
 
S.NO ENVAGAI THERVUGAL NO OF CASES RESULTS 
1. NAADI NADAI   
 Vathapitham 15 50% 
Pithavatham 10 33.3% 
Kabavatham 5 16.6% 
Kabapitham - - 
2. Sparisam - - 
3. Naa - - 
4. Niram - - 
5. Mozhi - - 
6. Vizhi - - 
7. Malam 5 12.5% 
8. Moothiram 5 12.5% 
 
 
OBSERVATION: 
The Naadinadai seen in Madhumega viranam patients were Vathapitham 50%, 
Pithavatham 33.3 %, Kabavatham 16.6%.Malam and Moothiram were affected 12.5% of 
patients. 
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NEERKURI REFERENCE  
 
S.NO NEERKURI NO OF CASES RESULTS 
1. Pale yellow 28 93.3% 
2. Yellow 2 6.6% 
3. Straw colour - - 
4. Dark yellow - - 
5. Colourless - - 
 
 
 
Observation: In this study 93.3% of the patients had Neerkkuri with pale yellow, 6.6% of 
Patients had yellow in colour. 
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NEIKURI: 
 
S.NO NEIKURI NO OF CASES RESULTS 
1. Vatham (Aravena neendathu) 0 0 
2. Pitham (Aazhi pol paraviyathu) 3 10% 
3. Kabam (Muthothu nindrathu) 27 90% 
 
 
 
Observation: In this study 90% of the patients had Neikuri with kabam (muththothu 
nindrathu), 10% patients had pattern of  pitha neer(Aazhipol paraviyathu). 
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OUT COME 
BATES GENSEN WOUND ASSESSMENT TOOL 
S.NO OP/IP NO 
 
NAME 
AGE/ 
SEX 
WOUND        
SCALE 
 
RESULTS 
BT AT 
1.  J74639 V.Devadas 61/M 29 13 GOOD 
2.  0069 S.Kumari 59/F 53 13 GOOD 
3.  J85814 Murugan 54/M 38 17 MODERATE 
4.  J17629 T.Govindhan 56/M 33 13 GOOD 
5.  J91684 Palaniappan 54/M 42 16 MODERATE 
6.  D94812 A.Venugopalan 65/M 51 25 MODERATE 
7.  J96164 G.Rajendran 57/M 31 13 GOOD 
8.  K691 R.Kumaraguru 65/M 50 13 GOOD 
9.  K00455 M.Ravi 50/M 38 30 POOR 
10.  J99448 G.Ravi 45/M 48 13 GOOD 
11.  K05003 R.Subramaniyan 63/M 64 25 MODERATE 
12.  K05039 A.Santha 56/F 35 13 GOOD 
13.  K10900 R.Ramadoss 59/M 30 25 POOR 
14.  K09067 V.Radha 63/F 29 13 GOOD 
15.  0411 P.Subramani 65/M 39 13 GOOD 
16.  J32794 P.Mayanathan 64/M 43 20 MODERATE 
17.  J42982 G.Baskaran 48/M 33 13 GOOD 
18.  K199215 Egambaram 45/M 43 20 MODERATE 
19.  K20157 A.Vasantha 40/F 45 35 POOR 
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20.  K04483 Kalyani 50/F 40 30 POOR 
21.  K19718 Deivanai 53/F 33 13 GOOD 
22.  K20390 V.Shanthi 52/F 43 13 GOOD 
23.  K23414 V.Ragu 40/M 30 20 POOR 
24.  K25805 Parimala 55/F 39 13 GOOD 
25.  J22165 Sundaraj 54/M 35 30 POOR 
26.  I73587 Dhayalan 54/M 45 35 POOR 
27.  K23594 Venkatesh 41/M 38 17 MODERATE 
28.  K30093 Philip 58/M 42 13 GOOD 
29.  K27535 Chandra 52/F 44 13 GOOD 
30.  K14536 Annamalai 43/M 35 20 POOR 
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OUTCOME: 
BATES GENSEN WOUND ASSESSMENT TOOL 
RESULTS:  
The trial drug Gandhi mathirai (Internal) and Sagala ranagalukum Kalimbu (External) were 
given to 30 patients for 48 days. 
 
S.NO RESULTS NO OF CASES RESULTS 
1. GOOD 15 50% 
2. MODERATE 7 23.4% 
3. POOR 8 26.6% 
 
 
 
Observation: The trial drug Gandhimathirai (Internal) and Sagalaranagalukum Kalimbu 
(External) were given to 30 patients for 48 days.Good improvement was observed in 15 
patients (50%), moderate improvement in 7 patients (23.4%), and mild improvement in 8 
(26.6%) cases. 
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BEFORE TREATMENT    AFTER TREATMENT 
Mr. R.Kumaraguru65/M 
Mrs.S.Kumari 59/F 
 
Mrs. V.Shanthi52/F 
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STATISTICAL ANALYSIS  
 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. 
The quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical 
significance. Paired„t‟ test was performed for determining the significance between before 
and after treatment.  
 
VARIABLE Obs MEAN±SD t value P value 
Before 
treatment 
30 39.93±8.072 
t=11.9576  0.0001 
After treatment 30 18.66±7.288 
 
 
 
 
The mean± standard deviation of BJWAT score at before and after treatment were 
39.93±8.072and 18.66±7.288 respectively which is statistically significant (t=11.9576, 
p=0.0001). 
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REDUCTION OF BJWAT SCORE BEFORE AND AFTER TREATMENT 
 
 
BJWAT SCORE 
NO OF CASES 
BEFORE TREATMENT AFTER TREATMENT 
13 0 15 
14-26 0 10 
27-52 28 5 
53-65 2 0 
 
 
 
According to BJWAT scoring, before treatment 28 patients were score between the 
no on 27-52 and 2 patients were score between 53-65.After treatment 15 patients was score 
13,10 patients were scored 14-26,5 patients were scored 27-52. 
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DISCUSSION 
 
Diabetic ulcer is one of the most severe manifestations of diabetes. A disease of 
great importance to public health due to its high incidence and prevalence and because of 
the high socioeconomic impact that it brings, since it is difficult to treat and requires 
prolonged work absenteeism.  
 
The raw drugs of Gandhi mathirai were identified and authentication certificate was 
obtained. Then the raw drugs were purified and GM was prepared as per the text Agasthiya 
vaithiya sinthamani. Phytosterols, Flavonoids, Amino acids, glycosides, Phenolic 
Compounds and Tannins, Saponins, Carbohydrates were present in this drug.  
 
The drug is free of microbial contamination, aflatoxins and pesticide residues. The 
heavy metals were not detected (arsenic, mercury, cadmium, lead). HPTLC finger printing 
analysis of the sample GM reveals the presence of three prominent peaks corresponds to presence of 
six versatile phyto components present with in it. Rf value of the peaks ranges from 0.06 to 0.93.  
Further the peak 2 occupies the major percentage of area of 56.11 % which denotes the abundant 
existence of such compound. Followed by this peak 1 and 2 occupies the percentage area of 16.15 
and 13.36%. The Acute and 90 days repeated oral toxicity studies did not show any toxic 
effects in the animals.  
 
Clinical study:  
For this study, 30 patients were selected and patients were treated in the OPD/IPD 
department of Sirappu Maruthuvam, in Ayothidoss Pandithar Hospital of National Institute 
of Siddha, Tambaram Sanatorium, Chennai – 600 047.  
 
The trial drug “GM” was given for 48 days. OPD patients were requested to visit the 
hospital once in 7 days. In each and every visit clinical assessment and prognosis were 
recorded. Laboratory investigations were done for all the cases before and after treatment. 
There were no variations in hepatic, renal and other parameters.  
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Based on various criteria, the data were collected and tabulated. The criteria were 
sex predominance, age distribution, occupation, dietary habits and incidence of the disease 
with reference to thinai, seasonal variation,clinical manifestations and Envagai thervu, 
Neerkuri and Neikuri. 
 
30 patients of both genders were recruited for this study. Among the 30 cases, 
21(70%) were males and 9 (30%) were females. Generally Diabetic ulcer occurs in both 
sexes, but a higher prevalence was noticed in males. In this study, more number of male 
cases was reported. 
 
Out of 30 cases, 20.1% patients were between 35 to 45 years, 36.6% patients 
between 46 to 55 years, 43.3% patients between 56 and 65 years. There were no differences 
in age in the onset of psoriasis between men and women with DU.  
 
Out of 30 patients reported, 20% of patients were work in agriculture, 3.3%of 
patients were work in security, fishermen, teacher, conductor, administrative work,6.6 % of 
patients were work in shopkeeper.36.6% of patients were work in other field. The results 
did not declare DU as an occupational related disease.  
 
In this present study, 60% of the patients were from Marutham (fertile Land) and the 
remaining (40%) from Neithal (Coastal) area. Considerable numbers of patients were 
reported from Marutham. In this present study, 46.6% patients were affected in Muthuvenil 
kaalam.  
  
Among the 30 patients selected for this study, 80% were non-vegetarian.20% 
patients were vegetarian. In this present study reveals DU occurs due to improper diet 
control and physical activity. 
 
Among the 30 patients selected for this study, 83.3% of patients were affect the 
duration between 15 days – 1 year, 13.3 % of cases were 2-5 years,3.3% of cases were long 
duration of symptoms. This study revels DU can occurs sudden onset and also prolong 
duration.  
Among the 30 patients, 100% of cases with the symptoms of ulcer with or without 
pain and oozing,83.3% of cases with the symptoms of foul smell,16% of patients were 
numbness foot,33.3% of patients with the symptoms of burning foot.  
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In Vaatham, Samanan and Viyanan were found to be affected in all the 30 patients. 
Abananwas found to be affected in 16.6% of patients. Among 30 patients, Saaram and 
Seneer, Oon were affected in all the cases.  
 
In Envagaithervugal, Malam was found affected in 5 cases. The Naadinadai seen in 
DU patients were Vaathapitham 50%, Pithavaatham 33.3 %, Kabavatham 16.6%.  
 
The haematological and biochemical parameters were tested for the patients treated 
with GM and it was found that there was no difference before and after treatment. This 
vouches for the safety of the trial drug administered as the values were well within the 
normal limits.  
 
The quantity variables were expressed as Mean ± Standard Error of Mean and 
qualitative data as percentage. A probability value of <0.05 was considered to be 
statistically significant.  
 
According to BJWAT scoring, before treatment 28 patients were score between the 
no on 27-52 and 2 patients were score between 53-65.After treatment 15 patients was score 
13,10 patients were scored 14-26,5 patients were scored 27-52. 
 
The mean± standard error of mean of BATES JENSAN WOUND ASSESSMENT 
TOOL score before and after treatment were 39.93 ± 8.072 and 18.66±7.288 respectively 
which is statistically significant (t= 11.9576, p <0.0001).  
 
The outcome of this study was clinically observed by BATES JENSAN WOUND 
ASSESSMENT TOOL Score, which showed encouraging results of good improvement in 
15 patients (50%), moderate improvement in 7 patients (23.4%), and poor improvement in 8 
(26.6%) cases.  
 
In this study, no adverse events were observed during the course of the treatment. At 
the end of the study, all the patients were advised to attend out-patient department of 
Sirappu Maruthuvam of NIS for further follow-up. 
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SUMMARY 
 
The raw drugs of GM were identified and authentication certificate was obtained.  
The physicochemical analysis of the prepared drug revealed that it was in the standard 
quality.  
HPTLC were done to identify phyto- chemicals and their Rf values were calculated.  
The toxic elements like Mercury, Arsenic and Cadmium are not detected. The Lead present 
in GM is within the WHO permissible limit.  
The study shows that GM did not produce any toxic effect in repeated oral toxicity study for 
90 days. 
This study has been approved by NIS/IEC/2016/11-15/14.10.2016 
The disease diabetic ulcer was taken for the clinical study with Gandhi mathirai andSagala 
ranagalukum kalimbu 30 cases were selected based on the approved protocol.  
Animal studies were done after obtaining approval from the Animal Ethical Committee 
(IAEC). Hence the study was safely executed on patients and there was no adverse drug 
reactions noted during the study period.  
The detailed study on diabetic ulcer with reference to its aetiology, pathogenesis, 
investigations, clinical features, diagnosis and treatment with trial drug was done.  
According to BJWAT scoring, before treatment 28 patients were score between the no on 
27-52 and 2 patients were score between 53-65.After treatment 15 patients was score 13,10 
patients were scored 14-26,5 patients were scored 27-52. 
The results were observed by BJWAT score. Among the 30 cases treated, 15(50%) cases 
showed Good improvement, 7(23.4%) cases showed Moderate improvement and 8(26.6%) 
cases showed Poor improvement.  
The mean± standard error of mean of BJWAT score at before and after treatment were 
39.93 ± 8.072 and 18.66±7.288 respectively which is statistically significant (t= 11.9576, p 
<0.0001).  
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CONCLUSION  
 
The herbo-mineral formulation Gandhi mathirai (GM) exhibited no toxicity on 
Repeated 90 days toxicity study.  
 
The present clinical study confirms the efficacy and safety of the trial drug “Gandhi 
mathirai” which is Siddha herbo-mineralformulation. It was found to be good resulting on 
Madhumega viranam patients in reducing clinical signs and symptoms like ulcer with and 
without pain, oozing present, foul smell, numbness foot, burning sensation.  
 
The quantitative outcome of BATES JENSAN WOUND ASSESSMENT score 
shows there is significant reduction between at the start and end of treatment i.e from 39.93 
± 8.072 and 18.66±7.288.The qualitative outcome shows there is 50% of cases had shown 
good improvement, 23.4% of cases had shown moderate improvement and remaining 
26.6% of cases had shown poor improvement.  
 
According to BJWAT scoring, before treatment 28 patients were score between the 
no on 27-52 and 2 patients were score between 53-65.After treatment 15 patients was score 
13,10 patients were scored 14-26,5 patients were scored 27-52. 
 
From the above results, the trail drug “Gandhi mathirai” was responded well in the 
treatment of Madhumega viranam.   
 
As a conclusion it can be stated that the Siddha herbo-mineral formulation GM can 
be used as a safe and efficacious drug towards the management of Madhumega viranam. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
“PRE CLINICAL AND OPEN CLINICAL TRIAL OF GANDHI MATHIRAI 
(INTERNAL MEDICINE) AND SAGALA RANANGALUKUMKALIMBU 
(EXTERNAL MEDICINE) IN THE TREATMENT OF MADHUMEGA VIRANAM 
(DIABETIC ULCER)”. 
 
FORM l - SCREENING & SELECTION PROFORMA  
 SL.NO:   OP/IP NO:   
 NAME:                                                  AGE/GENDER:             CONTACT 
NO: 
INCLUSION CRITERIA: 
Age: 30-65 years       Yes/No 
Patient includes diabetic ulcer    Yes/No 
Ulcer with or without Pain     Yes/No 
 Itching       Yes/No 
 Edema       Yes/No 
 Fibrinous exudates in the lesions    Yes/No 
Hyper pigmentation      Yes/No 
Inflammation & Induration     Yes/No 
Willing to give specimen of blood for the investigation Yes/No 
Permit to take photograph.     Yes/No 
EXCLUSION CRITERIA:  
Extensive and localized Gangrene require amputation Yes/No 
Osteo Myelitis       Yes/No 
Deep ulceration with bone, joint involvement   Yes/No 
Varicose ulcer       Yes/No 
Hansen‟s disease      Yes/No 
Tuberculous ulcer       Yes/No 
Any other systemic illness     Yes/No 
 
ADMITED TO TRIAL:  YES /NO   OPD          IPD  If yes, serial No:  
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                                Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
“PRE CLINICAL AND OPEN CLINICAL TRIAL OF GANDHI MATHIRAI 
(INTERNAL MEDICINE) AND SAGALA RANANGALUKUMKALIMBU 
(EXTERNAL MEDICINE) IN THE TREATMENT OF MADHUMEGA VIRANAM 
(DIABETIC ULCER)”. 
PRINCIPAL INVESTIGATOR: Dr. R.Vidhya 
 
FORM II – CLINICAL RESEARCH FORM 
 STUDY NO:                                                                      OP/ IP NO:    
 NAME:                                                                               AGE/GENDER:  
 ADDRESS:                                                                         CONTACT NO: 
                                                                                              RELIGION:  H / M / C / O          
OCCUPATION:                                                                  INCOME: 
MARRITAL STATUS:       MARRIED                            UNMARRIED         
DATE OF INITIAL ASSESSMENT:                                       
COMPLAINTS & DURATION:                          
 
PERSONAL HISTORY: 
PERSONAL HABITS YES NO IF YES SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
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HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
FAMILY HISTORY: 
 Whether this problem runs in family?         1. Yes              2. No         
 If yes, mention the relationship of affected person(s) 
1._________________ 2._________________ 
DIETARY HABIT:     1.Vegetarian                  2.Non-vegetarian 
  
MENSTURAL HISTORY AND OBSTETRIC HISTORY: 
FORM II a 
GENERAL EXAMINATION 
BEFORE  AFTER 
1. Body weight [Kg]  :                      
2. Height [cms]   :                        
3. Body Temperature [0F]  :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min  : 
6. Heart Rate / min   : 
7. Respiratory Rate /min  :  
   Yes           No  Yes           No 
8. Pallor  :        
9. Jaundice  :   
10. Clubbing  : 
11. Cyanosis  : 
12. Pedal Edema  : 
13. Lymphadenopathy         :  
14. Jugular venous pulsation  :   
 
VITAL ORGANS EXAMINATION:  Normal        Abnormal    Normal          
Abnormal 
1.  Heart 
2. Lungs  
3. Brain 
4. Liver 
5. Kidney 
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6. Spleen 
7. Stomach   
 
SYSTEMIC EXAMINATION:Normal          Abnormal   Normal          
Abnormal 
1. Cardio-vascular system 
2. Respiratory system         
3. Gastro intestinal system 
4. Central nervous system 
5.  Uro-genital system     
6.  Endocrine system        
 
SIDDHA SYSTEM OF EXAMINATION  
1. THEGI (TYPE OF BODY CONSTITUTION): 
1. Vaatha udal                     3. Kaba udal                   
2. Pitha udal                        4.Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji                                 3. Paalai 
2. Mullai                                  4. Neithal 
5. Marutham 
3. KAALAM: 
1. Kaar kaalam                              4. Pinpani kaalam 
2. Koothir kaalam                          5. Ilavenil kaalam 
3. Munpani kaalam                        6. Muthuvenil kaalam 
4. GUNAM: 
1. Sathuvam                            2. Rasogunam 
3. Thamogunam 
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5. PORIPULANGAL (SENSORY ORGANS): 
 1
st
day 8
th
day
 
15
th
day 22
nd
day 29
th
day 36
th
day  43
r
day 49
th
day 
Mei      
(skin) 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
Vaai   
(tongue) 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
Kan      
(eye) 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
Mooku 
(nose) 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
Sevi       
(ear) 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
Normal 
/Affected  
 
 
6. KANMENDRIYAM (MOTOR ORGANS): 
 1
st
 day 8
th
 day 15
th
day 22
nd
day 29
th
day 36
th
 day 43
rd
day 49
th
day 
Kai   
(upper 
limb) 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
Kaal  
(lower 
limb) 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
Vaai   
(speech) 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
Eruvai 
(excretory 
organ) 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
Karuvai 
(reproduct
ive 
organs) 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
 
 
Normal 
/Affected 
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7. KOSANGAL (SHEATH):          
 1
st
day
 
8
th
 day 15
th
day 22
nd
day 29
th
day 36
th
day 43
rd
day 49
th
day 
Annamayakosam Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Pranamayakosam  Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Manomaya kosam  Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Vignanamaya 
kosam  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Aananthamayakos
am  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
 
8. UYIR THATHUKKAL (THREE HUMOURS): 
A. VALI 
 1stDay 8thDay 15th day 22nd day 29th day 36th day 43rdday 49thday 
Praanan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Abaanan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Viyaanan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Udhaanan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Samaanan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Naagan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Koorman Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Kirukaran Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Devathathan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Dhananjeyan Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
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B) AZHAL 
 
1st 
day 
8th 
 Day 
15th 
day 
22nd 
day 
29th 
day 
36th 
 day 
43rd  day 49th  day 
Anarpitham 
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Prasakam  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Ranjagapitham 
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Aalosakam 
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Saathakam 
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
 
C. IYAM:             
 1stday 8th day 15th day 22nd day 29thday 36thday 43rd  day 49th day 
Avalambagam Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Kilethagam Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Pothagam Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Tharpagam
  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Santhigam
  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
 
9.SEVEN UDAL DHATHUS: (7 SOMATIC COMPONENTS)  
 1st 
day 
8th 
day 
15th 
day 
22nd day 29th 
day 
36th  day 43rd day 49th  day 
Saaram Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Senneer  Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Oon Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Kozhuppu Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Enbu Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Moolai Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Sukkilam / 
Suronitham  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
Normal 
/Affected  
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ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION]  
I. NAADI: [PULSE PERCEPTION] 
II. SPARISAM: 
1
st
day 8
th
 Day 15
th
 
Day 
22
nd 
day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
        
 
III. NAA:[TONGUE] 
1
st
day 8
th
 Day 15
th
 
Day 
22
nd 
Day 
29
th
 
Day 
36
th 
Day 
43
rd
 
Day 
49
th
 Day 
        
 
VI.NIRAM: [COMPLEXION]   
 1. Vaatham                   2. Pitham  3.Kabam 
 
V.MOZHI: [VOICE] 
1. High Pitched              2. Low Pitched           3. Medium Pitched 
 
VI.VIZHI: [EYES]  
1
st
Day 8
th
 Day 15
th
 Day 22
th
 Day 29
th
 Day 36
th
 Day 43
rd
 Day 49
th
 Day 
        
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
     Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
1
st
day
 
8
th 
day
 
15
th
day 22
nd
day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
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VIII. MOOTHIRAM [URINE EXAMINATION]  
 
Neerkkuri Before treatment After treatment 
Niram 
 
  
Manam   
Edai   
Nurai   
Enjal   
 
NEIKURI Before treatment After  treatment 
Aravu (Serpentine fashion)   
Aazhi (Annular/Ringed 
fashion) 
  
Muthu (Pearl beaded 
fashion) 
  
Kalappu (Mixed fashion)   
Other fashion   
 
 
CLINICAL EXAMINATION OF ULCER 
INSPECTION: 
1. Location:------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
2. Size   : 
3. Colour   :Normal           Reddish                 Black                 
Greyish 
4. Shape   :Regular           Irregular   
5. Fibrinous exudate :No            Mild                   Moderate          Severe 
6. Erythema  :Present  Absent 
7. Bleeding  :Present  Absent 
8. Crusting  :Present  Absent  
9. Inflammation  :Present                Absent 
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10. Induration  :Present               Absent   
 
11. Edges   : 
 
12. Margin  :     
YES   NO 
13. Ulcération  : 
14. Macule   :    
15. Papule   : 
16. Pustule  :  
17. Blister   : 
18. Vesicle  :   
19. Pigmentation  : Normal  Hypo  Hyper  
 
FORM II B-CLINICAL ASSESSMENT DURING AND AFTER TRIAL 
 OP/ IP NO:                     STUDY NO:                       NAME: 
 1
st
day 8
th
 Day 15
th
 Day 22
th
 Day 29
th
 Day 36
th
 
Day 
43
rd
 
Day 
49
th
 
Day 
 
Size         
Shape         
Depth         
 
Inflammation 
 
        
Induration         
Surrounding 
Skin color  
        
Exudate type         
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Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                           Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
       
Exudate 
amount 
        
Peripheral 
oedema 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSSPANDITHARHOSPITAL 
CHENNAI – 600 047. 
“PRE CLINICAL AND OPEN CLINICAL TRIAL OF GANDHI MATHIRAI 
(INTERNAL MEDICINE) AND SAGALA RANANGALUKUMKALIMBU 
(EXTERNAL MEDICINE) IN THE TREATMENT OF MADHUMEGA VIRANAM 
(DIABETIC ULCER)”. 
PRINCIPAL INVESTIGATOR: Dr. R.Vidhya 
FORM-III – LABORATORY INVESTIGATIONS PROFORMA 
STUDY NO:           NAME:              OP/IPNO:AGE/GENDER:    
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE TMT 
( DATE) 
AFTER TMT 
(DATE) 
Hb( gm/dl) 
M:12-15 
F:11.5-14 
  
T.WBC (cells/cu.mm) 4000-11000   
DIFFERENTIAL COUNT 
(%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
T.RBC(million cells/cu.mm) M:4.0-5.5 
  F:3.5-4.5 
  
  ESR(mm/hour) ½ hr M:1-13 
F:1-20 
  
  1 hr   
 
Blood Investigations 
Normal 
Values 
Before TMT 
(DATE) 
After TMT 
(DATE) 
Blood glucose 
(mg/dl) 
                Fasting    70-110   
                PP    80-140   
                Random    80-120   
 
RFT (mg/dl) 
 
       Blood urea 
   16-50   
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Serum creatinine    0.6-1.2   
Serum uric acid 
M:3-9  
F:2.5-7.5 
  
LFT (mg/dl) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect bilirubin    0.2-0.7   
SGOT  (IU/L)    0-40   
SGPT (IU/L)    0-35   
Alkaline 
phosphatase(IU/L) 
   80-290   
OTHER TEST 
HBsAG 
VDRL 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:          Signature of the HOD 
 
 
Urine investigations Before TMT( Date) After TMT ( Date) 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
Neerkuri   
Neikuri    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, 
       CHENNAI – 600 047. 
 
 
 
“PRE CLINICAL AND OPEN CLINICAL TRIAL OF GANDHI MATHIRAI 
(INTERNAL MEDICINE) AND SAGALA RANANGALUKUMKALIMBU 
(EXTERNAL MEDICINE) IN THE TREATMENT OF MADHUMEGA VIRANAM 
(DIABETIC ULCER)”. 
FORM V– PATIENT INFORMATION SHEET 
 
Name of Principal Investigator: Dr.R.Vidhya 
Name of the institute: National Institute of Siddha, 
 Tambaram Sanatorium, 
 Chennai-47. 
 
INFORMATIONS SHEET FOR PATIENT PARTICIPATED IN THE OPEN 
CLINICAL TRIAL. 
 I, Dr.R.Vidhya,studying M.D (Siddha) at National Institute of Siddha, Tambaram 
Sanatorium is  going to do a trial on “Madhumega viranam” (Diabetic ulcer).Diabetic ulcer 
commonly seen in diabetic individual, it is commonly occur in toes, feet particularly in sole, 
Leg is also affected, In this regard; I am in a need to ask you few questions. I will maintain 
confidentiality of your comments and data obtained. There will be no risk of disclosing your 
identity and no physical, psychological or professional risk is involved by taking part in this 
study. Taking part in this study is voluntary. No compensation will be paid to you for taking   
part in this study. 
 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in the 
study may be of benefit to the community, as it may help us to understand the problem of 
defaulters and potential solutions. 
 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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“GANDHI MATHIRAI” (Internal medicine) 1 (b.i.d) and „SAGALA RANANGALUKUM 
KALIMBU” (External medicine) for 48days.  
 
 The information I am collecting in this study will remain between you and the 
principal investigator (I). I will ask you few questions through a questionnaire. I will not 
write your name on this form. Your name won‟t be mentioned in the lab investigation form 
instead a code will be used.The questionnaire will take approximately 20 minutes of your 
time. 
If you want to know more about this study before taking part, you can contact 
Dr.R.Vidhya, PG Scholar, principal investigator of this study,National Institute of Siddha, 
Chennai-47. You can also contact the Member-secretary of Ethics committee, National 
Institute Siddha, Chennai 600047, Tel.No: 91-44-22380789, for rights and participation in 
the study.     
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¾¸Åø ÀÊÅõ 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É-¦ºý¨É-47 
 
ÁÐ§Á¸ Å¢Ã½õ ±ýÛõ §¿¡öì¸¡É ¦¸ó¾¢ Á¡ò¾¢¨Ã (¯û ÁÕóÐ) ÁüÚõ 
º¸ÄÃ½¸ÙìÌõ ¸Ç¢õÒ(¦ÅÇ¢ ÁÕóÐ) º¢ò¾ ÁÕóÐ¸Ç¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ 
ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
Ó¾ý¨Á ¬öÅ¡Ç÷ ¦ÀÂ÷ : ÁÕòÐÅ÷. þÃ¡.Å¢òÂ¡, 
 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷  : §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
     ¾¡õÀÃõ, º¡Éð§¼¡¡Ã¢Âõ, 
     ¦ºý¨É - 47. 
 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý (ÁÕòÐÅ÷-
þÃ¡.Å¢òÂ¡),ÁÐ§Á¸ Å¢Ã½õ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.ÁÐ§Á¸ 
Å¢Ã½õ ±ýÛõ §¿¡Â¡ÉÐ §¿¡Â¡Ç¢ ¿£ñ¼ ¸¡ÄÁ¡¸ þó§¿¡Â¢É¡ø À¡¾¢ì¸ôÀðÎ «¾ý 
¸¡Ã½Á¡¸ Å¢Ã½õ ¯ñ¼¡¸¢ «¾¢ø ÅÄ¢ «øÄÐ ÅÄ¢ þøÄ¡Áø, ÌÕ¾¢,º¢ú,Å¢ì¸õ,§¾¡Ä¢ý 
¿¢Èõ Á¡Èø,«Ã¢ôÒ ¬¸¢Â ÌÈ¢Ì½õ ¯ñ¼¡ìÌõ §¿¡Â¡Ìõ. 
þó¾ ¬Ã¡öîº¢ ºõÁó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¨ÅÂ¡É 
¬öÅ¸ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç ÀÃ¢§º¡¾¨ÉìÌ ¯ðÀÎò¾×õ ¯û§Çý, «Ð ºõÁó¾Á¡É 
¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡ö ¨Åì¸ôÀÎõ ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý.þ¾¢ø 
ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ ¦¾¡¨¸Ôõ ÅÆí¸ôÀ¼Á¡ð¼¡Ð.þó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð 
¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ±üÀÎõ Àðºò¾¢ø §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø ¾ì¸ 
º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
 
þó¾ ¬Ã¡öîº¢ìÌ ¾í¸Ç¢ý Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø ¯ûÁÕó¾¡¸ 
¦¸ó¾¢ Á¡ò¾¢¨Ã 1 þÕ§Å¨Ç (¸¡¨Ä, Á¡¨Ä) ¯½×ìÌ À¢ý 48 ¿¡ð¸û ¯ð¦¸¡ûÇ 
§ÅñÎõ,¦ÅÇ¢ÁÕó¾¡¸ º¸ÄÃ½¸ÙìÌõ ¸Ç¢õÒ.þó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸ §º÷ó¾ 
À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ þø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ 
¦¸¡ûÇÄ¡õ.þó¾ ¬Ã¡öîº¢ ºõÁó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ 
Ó¾ý¨Á ¬öÅ¡ÇÃ¡É ÁÕòÐÅ÷ þÃ¡.Å¢òÂ¡ (Àð¼ §ÁüÀÊôÀ¡Ç¡÷ º¢ÈôÒ ÁÕòÐÅ Ð¨È) 
«Ï¸×õ.¨¸§Àº¢ ±ñ: 
 
§ÁÖõ þó¾ ¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈÀðÎûÇÐ.§ÁÖõ ¯½× Ó¨ÈÂ¢ø 
ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ ¸¡ìÌÁ¡Ú «È¢×Úò¾ôÀÎ¸¢ÈÐ. 
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FORM-V – CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant 
In case of illiterate participant 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                   
Date: 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)  
  
 
 
 
 
 
Left thumb Impression of the Participant 
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´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø-º¡ýÈÇ¢ì¸ôÀð¼Ð 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
«§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É,¦ºý¨É-47. 
ÁÐ§Á¸ Å¢Ã½õ §¿¡öì¸¡É ¦¸ó¾¢ Á¡ò¾¢¨Ã(¯û ÁÕòÐ) ÁüÚõ º¸ÄÃ½í¸ÙìÌõ 
¸Ç¢õÒ (¦ÅÇ¢ÁÕóÐ) º¢ò¾ ÁÕóÐ¸Ç¢ý ÀÃ¢¸Ã¢ôÒ ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ 
¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
   ´ôÒ¾ø ÀÊÅõ-¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀðÎûÇÐ 
 
¿¡ý þó¾ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡ÂÇ¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø 
±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
§¾¾¢ :         ¨¸¦Â¡ôÀõ: 
þ¼õ :          ¦ÀÂ÷: 
   
     §¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø  
±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ ÁÕòÐÅ 
ÅÆ¢Ó¨È ÀüÈ¢Ôõ,¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ì ¸ñ¸¡½¢ì¸×õ, «¾¨É 
À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢ ¾¢Õô¾¢ «Ç¢ìÌõ 
Å¨¸Â¢ø ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
 
¿¡ý þó¾ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ 
þó¾ ¬öÅ¢Ä¢ÕóÐ ±ý¨É Å¢ÎÅ¢òÐì ¦¸¡ûÙõ ¯Ã¢¨Áò ¦¾Ã¢ó¾¢Õì¸¢§Èý. ¿¡ý  
±ýÛ¨¼Â Í¸ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Áì ¦¸¡ñÎ ÁÐ§Á¸ Å¢Ã½õ ±ýÛõ 
§¿¡öì¸¡É ¦¸ó¾¢ Á¡ò¾¢¨Ã(¯û ÁÕóÐ) ÁüÚõ º¸ÄÃ½¸ÙìÌõ ¸Ç¢õÒ(¦ÅÇ¢ÁÕóÐ) 
º¢ò¾ ÁÕóÐ¸Ç¢ý ÀÃ¢¸Ã¢ôÒ ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ 
´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
§¾¾¢  :       ¨¸¦Â¡ôÀõ : 
þ¼õ :       ¦ÀÂ÷  : 
 
        º¡ðº¢¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
        ¯È×Ó¨È: 
 
Å¢Ã¢×¨ÃÂ¡Ç÷ ¨¸¦Â¡ôÀõ:     Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ: 
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FORM VII -A- WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................   
3. NAME: ………………………    
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes / No 
Irregular treatment:      Yes / No 
Shift of locality:                                     Yes / No 
Increase in severity of symptoms:     Yes / No 
Development of severe adverse drug reactions:   Yes / No 
Development of adverse event:                                             Yes / No 
 
(If YES, give the details of adverse reaction in Form VII -B – Adverse Reaction Form / 
Pharmaco Vigilance Form) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
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FORM VII -B – ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCURS: 
DESCRIPTION OF ADVERSE REACTION: 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
¦ºý¨É-47 
 
ÁÐ§Á¸ Å¢Ã½õ §¿¡öì¸¡É ¦¸ó¾¢ Á¡ò¾¢¨Ã(¯û ÁÕòÐ) ÁüÚõ 
º¸ÄÃ½í¸ÙìÌõ ¸Ç¢õÒ (¦ÅÇ¢ÁÕóÐ) º¢ò¾ ÁÕóÐ¸Ç¢ý ÀÃ¢¸Ã¢ôÒ ¾¢È¨Éì 
¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ.  
 
Ó¾ý¨Á ¬öÅ¡Ç÷ ¦ÀÂ÷ : ÁÕòÐÅ÷. þÃ¡.Å¢òÂ¡. 
 
ÀÊÅõ VIII¯½× ÀÃ¢óÐ¨Ã ÀÊÅõ 
¸¡ö¸È¢¸û: 
 
ÀÆí¸û 
À¡Éí¸û 
«¨ºÅ ¯½× Å¨¸¸û 
 
 
 
 
º¡ôÀ¢¼ì ÜÊÂ¨Å º¡ôÀ¢¼ì Ü¼¡¾¨Å 
¸ò¾Ã¢ì¸¡ö, «Å¨Ãì¸¡ö, À¡¸ü¸¡ö, 
¦Åñ¨¼ì¸¡ö,¦¸¡ò¾Å¨Ã,¦Åí¸¡Âõ, 
áø§¸¡ø, ¸¡Ä¢À¢ÇÅ÷, ¦Åû¨Çôâº½¢, 
Óð¨¼§¸¡Š, ÓÕí¨¸ì¸¡ö, 
Å¡¨Æò¾ñÎ,  Ò¼Äí¸¡ö, ÀÄ¡ì¸¡ö, 
À£ýŠ, ¸£¨Ã Å¨¸¸û, ÀÂÚ Å¨¸¸û,  
 
Å¡¨Æì¸¡ö,¯Õ¨Çì¸¢ÆíÌ, ¸¡Ãð, 
À£ðåð ,§ºôÀí¸¢ÆíÌ º÷ì¸¨Ãôâº½¢ 
¸¢ÆíÌ Å¨¸¸û, þÇ¿£÷, º¢ÅôÒ 
ÓûÇí¸¢, ¿¢Äì¸¼¨Ä, Óó¾¢Ã¢ 
 
º¡ôÀ¢¼ì ÜÊÂ¨Å º¡ôÀ¢¼ì Ü¼¡¾¨Å 
º¢È¢Â ¬ôÀ¢û1 ÀôÀ¡Ç¢ô ÀÆõ 1 ÐñÎ 
º¢È¢Â ¬ÃïÍ ¦ÅûÇÃ¢ô ÀÆõ 1 ÐñÎ, 
§ÀÃ¢ì¸¡ö º¢È¢ÂÐ 1/2 ÐñÎ, 
¦¸¡öÂ¡ôÀÆõ º¢È¢ÂÐ 1 
 
§ÀÃ¢îºõ ÀÆõ ÀÄ¡ôÀÆõ, ¯Ä÷ó¾ ÀÆ 
Å¨¸¸û, Å¡¨ÆôÀÆõ, ÊýÉ¢ø 
«¨¼ì¸ôÀð¼ ÀÆ Å¨¸¸û, ¦ÀÃ¢Â 
¬ôÀ¢û, ºô§À¡ð¼¡, Á¡õÀÆõ, ¦ÀÃ¢Â 
¦¸¡öÂ¡ôÀÆõ 
 
º¡ôÀ¢¼ì ÜÊÂ¨Å º¡ôÀ¢¼ì Ü¼¡¾¨Å 
º÷ì¸¨Ã þøÄ¡¾ ¸¡À¢ Ë ±ÖÁ¢î¨º 
ƒ¥Š, Ýô, §º¡¼¡, ¾ì¸¡Ç¢ ƒ¥Š, 
þÇ¿£÷ (º÷ì¸¨Ã ¸ðÎôÀ¡ðÊø 
þÕó¾¡ø) 
 
º÷Àò Å¨¸¸û º÷ì¸¨Ã Å¨¸¸û, 
ÁÐ Å¨¸¸û, µÅøÊý, †¡÷Ä¢ìŠ, 
§À¡÷ýÅ¢ð¼¡,  
 
º¡ôÀ¢¼ì ÜÊÂ¨Å º¡ôÀ¢¼ì Ü¼¡¾¨Å 
Óð¨¼ ¦Åû¨Çì¸Õ Óð¨¼Â¢ø Áïºû ¸Õ, ¸ÕÅ¡Î, Á£ý, 
®Ãø, ã¨Ç, ¦¿ïÍì¸È¢, ¬ðÎì¸È¢,  
§¸¡Æ¢ì¸È¢ 
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FORM VIII DIETARY ADVICE FORM 
 
Vegetables 
 
Fruits 
 
Drinks 
Non vegetarian foods 
 
Eat Avoid 
Brinjal,Broad beans,Bitterguord,Lady‟s 
finger, Cluster beans, Onion, 
Turnip,Cauliflower, White pumpkin, 
Cabbage, Drumstick,Spadix of the Plaintain 
,Cucumber,Beans, Green vegetables, Pulses 
 
Unripe plantain, Potato, Carrot, Beetroot, 
Colachasia, Sweet pumpkin,Tubers, Tender 
coconut, Radish, Ground nut, Cashewnut 
 
 
Eat Avoid 
Small Apple 1, Papaya 1piece ,Small 
Orange, Muskmelon 1 piece, small Pear 
(1/2) piece, Guava small piece 1 
 
 
Dates,Jackfruit,Dried fruits, Banana, Tinned 
fruits, Apple, Sapota, Mango,Guava 
Eat Avoid 
Coffee, Tea without sugar,Soda,Lime juice, 
Soup, Tomato juice, Tender coconut(If 
sugar level is controlled ) 
 
Sugar items, Honey, 
Oval,Horlicks,Bournvita 
 
Eat Avoid 
Egg yolk,  
 
Dry fish, Meat,Chicken 
 
